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Abstract	
	 Apolipoprotein	L-1	(APOL1)	is	a	secreted	protein	that	provides	protection	against	several	protozoan	parasites	due	to	its	channel	forming	properties.	Recently	evolved	variants,	G1	and	G2,	increase	kidney	disease	risk	when	present	in	two	copies.	In	mammalian	cells,	overexpression	of	G1	and	G2,	but	not	wild-type	G0,	leads	to	swelling	and	eventual	lysis.	However,	the	mechanism	of	cell	death	remains	elusive	with	multiple	pathways	being	invoked,	such	as	autophagic	cell	death	mediated	by	a	BH3	domain	in	APOL1,	which	we	evaluated	in	this	study.	We	hypothesized	that	the	common	trigger	for	these	pathways	is	the	APOL1	cation	channel,	which	is	pH-gated	and	requires	acidification	followed	by	neutralization	to	function,	conditions	met	along	the	secretory	pathway.	Testing	ion	selectivity	in	planar	lipid	bilayers	revealed	that	all	APOL1	variants	conduct	Ca2+.	Furthermore,	we	discovered	that	cellular	toxicity	of	G1	and	G2	was	Ca2+-dependent	and	led	to	a	cytosolic	Ca2+	influx,	without	ER	Ca2+	release,	quantified	via	high-throughput	live-cell	microscopy.	This	influx	preceded	swelling	and	required	prior	plasma	membrane	(PM)	localization,	demonstrated	by	expression	of	tagged	APOL1	in	the	Retention	Using	Selective	Hooks	system.	G0	was	also	cytotoxic	if	acidified	and	neutralized	after	PM	localization,	suggesting	regulation	along	the	secretory	pathway	that	G1	and	G2	evade.	Furthermore,	we	report	that	PM	wound	repair	mediated	by	ESCRT-III	promotes	cell	survival	against	APOL1	cytotoxicity,	and	that	the	putative	BH3	domain	is	dispensable	for	APOL1-mediated	cell	death.	These	results	indicate	that	APOL1	channel	activity	drives	cytotoxicity	via	Ca2+	influx,	and	as	a	potent	signaling	molecule,	Ca2+	may	activate	previously	reported	cell	death	pathways.	
	 v	
																	Dedicated	to		
Alisa		
	
	
	
	
	
	
	
	
	 vi	
Acknowledgements	
	
	 This	work	would	not	have	been	completed	without	the	love	and	support	of	many,	and	to	those	I	want	to	say	Thank	You	from	the	bottom	of	my	heart.	Jayne	Raper	for	being	a	kind	and	generous	person,	and	an	ambitious	mentor	who	won’t	let	a	good	story	get	in	the	way	of	proper	controls	and	who	has	the	mad	ideas	that	always	end	up	being	right.	Being	in	this	lab	and	under	her	mentorship	has	helped	me	achieve	heights	as	a	young	scientist	I	would	not	have	thought	possible.	Russell	Thomson	for	his	unassuming	brilliance	and	generosity,	guidance,	and	dealing	with	me	over	too	many	kidney	conferences.	Charles	Schaub	for	being	a	constant	sounding	board	and	great	motivator	in	and	out	of	the	lab,	and	also	for	not	ditching	me	when	I	was	hopping	around	on	one	leg	in	Denmark.	The	rest	of	the	Raper	lab,	past	and	present,	Jyoti,	Joey,	Daniella,	Ronnie,	Maria,	Anibelky,	Izzy,	Bernardo,	Zayd,	Daphne,	and	the	many	students	we’ve	shared	the	joy	of	science	with,	for	always	being	helpful	and	providing	stimulating	discussions.	Thanks	to	the	fantastic	students	I’ve	had	the	pleasure	of	mentoring	over	the	years,	Gagandeep,	Sim,	Enmily,	Katie,	and	Nailya.	Gratitude	is	extended	to	the	rest	of	the	Hunter	Biology	Department,	with	particular	thanks	to	the	Feinstein	and	Bratu	labs	and	Livia	Johnson	for	showing	me	the	(fluorescent)	light.	An	extra	dose	of	gratitude	to	all	the	fellow	graduate	students	from	Hunter,	who	have	made	these	past	6	years	in	the	trenches	enjoyable.	A	massive	thank	you	to	Ryan	Schreiner	for	all	his	support,	game-changing	ideas,	and	commitment	to	making	this	project	possible.		
	 vii	
	 A	thank	you	to	the	members	of	my	committee	over	the	years	for	pushing	me	to	succeed	and	giving	me	some	excellent	ideas	along	the	way,	Mitch	Goldfarb,	Paul	Feinstein,	Vincent	Racaniello,	Norma	Andrews,	and	David	Friedman.			 Most	importantly,	a	thank	you	to	my	friends	and	family.	Mike,	Steph	and	Li,	have	been	the	best	siblings	any	brother	could	ask	for,	and	not	to	mention	the	best	friends	I’ve	ever	had.	And	to	my	parents	for	their	complete	selflessness	in	supporting	me	since	Day	One.	And	of	course	to	Alisa,	for	convincing	me	to	become	a	scientist,	supporting	me	every	single	step	of	the	way,	and	making	life	worth	living.		
Contributions	to	this	project:	Jayne	Raper	for	her	guidance	and	shifting	focus	to	calcium	and	the	wound	healing	pathways.	Russell	Thomson	for	rAPOL	purification	and	planar	lipid	bilayer	experiments.	Ryan	Schreiner	for	the	RUSH	and	setting	up	the	microscopy	experiments.	Sim,	Anibelky,	Katie,	and	Nailya	for	their	assistance	in	performing	many	of	the	experiments	leading	up	to	or	within	this	body	of	work.	Alisa	Gaskell	for	offering	technical	advice,	helping	to	put	this	thesis	together,	and	putting	me	in	contact	with	Nirav.	Nirav	Malani	for	writing	the	script	in	R	and	coming	up	with	ways	to	analyze	our	large	data	sets.	Christian	Andersen	and	Gitte	Ratz	for	teaching	us	how	to	perform	protein	purifications	and	for	kindly	providing	the	FlpIn	293	cells.	Jeffrey	Kopp	for	kindly	providing	us	with	podocytes.	
	 viii	
Table	of	Contents	Title	Page	 	 	 	 	 	 	 	 	 	 i					 	Copyright	Page	 	 	 	 	 	 	 	 	 ii	Approval	Page	 	 	 	 	 	 	 	 	 iii	Abstract	 	 	 	 	 	 	 	 	 	 iv	Acknowledgements	 	 	 	 	 	 	 	 	 vi	List	of	Sections	 	 	 	 	 	 	 	 	 viii	List	of	Figures	 	 	 	 	 	 	 	 	 x	Abbreviations	 	 	 	 	 	 	 	 	 xii		
Introduction	1.				The	APOL	Gene	Family	 	 	 	 	 	 	 	 						1	2.				APOL1	Provides	Immunity	Against	African	Trypanosomes	 	 	 						1	3.				APOL1	Kills	Trypanosomes	by	Forming	pH-gated	Cation-Selective	Channels			3	4.				A	Molecular	Arms	Race	Between	Humans	and	Trypanosomes						 		 						6	5.				The	Casualties	of	War:	Newly	Evolved	APOL1	Alleles	Cause	Kidney	Disease				9	6.				Intracellular	APOL1	Leads	to	Kidney	Disease	 	 	 	 	 						10	7.				APOL1	and	Autophagy	 	 	 	 	 	 	 	 						12	8.				The	Cytotoxicity	and	Cell	Death	Mechanisms	of	the	APOL	Family	 	 						13	9.				Cytotoxicity	of	APOL1	Is	Linked	with	Multiple	Cell	Death	Pathways	 						14	10.		APOL1	Channel	Formation	at	the	PM		 	 	 	 	 	 						16	11.		Ca2+	Signaling	 	 	 	 	 	 	 	 	 						18	12.		Ca2+	Activated	Wound	Healing	Pathways	Protect	Cells	From	PFTs	 	 						20	13.		Research	Questions	 	 	 	 	 	 	 	 						23		
Materials	and	Methods	 	 	 	 	 	 		 				24		
Chapter	1:	Assessing	the	Function	of	the	APOL1	BH3	Domain	and	
the	Cytotoxicity	of	the	APOL	Family	Members	 	 	 				43	1.				Introduction	 	 	 	 	 	 	 	 					 					43	2.				Results	 	 	 	 	 	 	 	 	 	 					44	I.				The	Putative	BH3	Domain	of	APOL1	is	Dispensable	for	Cytoxicity	and												Trypanolysis	 	 	 	 	 	 	 	 	 					44	II.			Assessing	the	Cytotoxicity	of	the	APOL	Family	 	 	 	 					48	
	 ix	
3.			Discussion	 	 	 	 	 	 	 	 	 					53		 	 	
Chapter	2:	APOL1-G1	and	G2	Form	Ca2+-Permeable	Channels	at	the	
Plasma	Membrane	that	Lead	to	Cell	Death	 	 	 	 				58	1.				Introduction	 	 	 	 	 	 	 	 	 					58	2.				Results	 	 	 	 	 	 	 	 	 	 					59	I.					Expression	of	APOL1	in	FlpIn	TREX293	Stable	Cell	Lines	Represents	a	Relevant									Cell	Culture	Model	of	APOL1-Mediated	Kidney	Disease	 	 	 					59	II.			The	APOL1	Channel	Conducts	Ca2+	 	 	 	 	 	 					62	III.	The	Cytotoxicity	of	APOL1	Requires	Ca2+	 	 	 	 	 					63	IV.		Expression	of	G1	and	G2,	but	not	G0,	Leads	to	an	Increase	in	Intracellular	Ca2+									that	Precedes	Cell	Swelling	and	Membrane	Damage	 	 	 	 					65	V.			The	Cytotoxicity	of	APOL1	Requires	Trafficking	from	the	Endoplasmic	Reticulum		 	 	 	 	 	 	 	 	 	 	 					70	VI.		APOL1-Mediated	Ca2+	Influx	Requires	Trafficking	from	the	ER	 	 					76	VII.	APOL1	Localizes	to	the	Plasma	Membrane	after	Release	from	the	ER	 					79	VIII.	Extracellular	Ca2+	is	the	Source	for	G1	and	G2-Mediated	Influx	and	Cytotoxicity		 	 	 	 	 	 	 	 	 	 	 					85	IX.			Regulation	Along	the	Secretory	Pathway	Likely	Prevents	G0	Cytotoxicity	 					89	3.	Discussion	 	 	 	 	 	 	 	 	 	 					93	
Chapter	3:	APOL1	and	the	Wound	Healing	Pathways	 	 			104	1.				Introduction	 	 	 	 	 	 	 	 	 					104	2.				Results	 	 	 	 	 	 	 	 	 	 					105	3.				Discussion	 	 	 	 	 	 	 	 	 					111		
Summary	 	 				 	 	 	 	 	 	 	 			115		
Appendix	 	 				 	 	 	 	 	 	 	 			116	
	
Bibliography	 	 				 	 	 	 	 	 	 			117			
	 x	
List	of	Figures		Figure	1:	Schematics	of	the	cellular	wound	healing	pathways	 	 	 22		Figure	2:	The	predicted	BH3	domain	of	APOL1-G0	is	dispensable	for	trypanolysis	and	cytotoxicity	 	 	 	 	 	 	 	 	 47		Figure	3:	The	APOL	gene	family	encodes	for	cytotoxic	proteins	 	 	 50-51		Figure	4:	Tagging	the	APOLs	can	greatly	reduce	their	cytotoxicity	and	is	possibly	deleterious	to	function	 	 	 	 	 	 	 	 52		Figure	5:	Expression	of	G1	and	G2,	but	not	G0,	in	FT293	cells	is	cytotoxic	 60		Figure	6:	Expression	of	G1	and	G2,	but	no	G0,	at	physiological	levels	leads	to	cytotoxicity	 	 	 	 	 	 	 	 	 	 61		Figure	7:	The	APOL1	channel	is	permeable	to	Ca2+,	and	APOL1-induced	cytotoxicity	is	Ca2+-dependent		 	 	 	 	 	 	 	 	 64		Figure	8:	Increasing	the	concentration	of	another	divalent	cation,	Mg2+,	does	not	lead	to	a	significant	increase	in	cytotoxicity	 	 	 	 	 65		Figure	9:	Validation	of	GCaMP6f	function	in	FT293	cells	(Movie	1)	 	 67		Figure	10:	Expression	of	G1	and	G2	leads	to	Ca2+	influx	prior	to	cell	swelling	(Movie	2)	 	 	 	 	 	 	 	 	 	 68	
	Figure	11:	G1	and	G2	lead	to	a	sustained	influx	of	Ca2+	that	precedes	cell	swelling		 	 	 	 	 	 	 	 	 	 69		Figure	12:	APOL1-mediated	Ca2+	influx	and	cytotoxicity	requires	trafficking	from	the	endoplasmic	reticulum	 	 	 	 	 	 	 	 72-73		Figure	13:	The	toxicity	of	RUSH-APOL1	is	Ca2+-dependent,	and	expression	and	ER	release	of	RUSH-G1	and	G2	leads	to	Ca2+	influx	in	CHO	cells	 	 	 74		Figure	14:	APOL1	is	not	retained	in	the	ER	and	remains	cytotoxic	with	a	KDEL	or	KKXX	target	sequence	 	 	 	 	 	 	 	 75		Figure	15:	Expression	of	RUSH-G1	and	G2	leads	to	Ca2+	influx,	swelling,	and	lysis	only	after	release	from	the	ER	(Movie	3)	 	 	 	 	 	 77	
	Figure	16:	Expression	and	ER	release	of	RUSH-G1	and	G2	leads	to	Ca2+	influx	and	lysis	in	CHO	cells	(Movie	4)	 	 	 	 	 	 	 	 78	
	 xi	
Figure	17:	RUSH-G0	traffics	to	the	PM	within	90min	of	biotin-mediated	release	from	the	ER	 	 	 	 	 	 	 	 	 	 81	
	Figure	18:	RUSH-APOL1	traffics	to	the	PM	after	biotin-mediated	release	from	the	ER		 	 	 	 	 	 	 	 	 	 82-84		Figure	19:	Validating	the	simultaneous	use	of	GCaMP6f	with	the	ER	Ca2+	sensor	ER-LAR-GECO	(Movie	5)		 	 	 	 	 	 	 	 86		Figure	20:	Extracellular	Ca2+	is	the	source	for	APOL1-mediated	influx	 	 87		Figure	21:	APOL1-mediated	increase	of	cytosolic	Ca2+	is	not	due	to	ER	Ca2+	release	(Movie	6)	 	 	 	 	 	 	 	 	 	 88		Figure	22:	RUSH-G0	is	cytotoxic	if	acidified	and	neutralized	after	PM	localization		 	 	 	 	 	 	 	 	 	 90		Figure	23:	Proposed	model	of	APOL1	cytotoxicity	 	 	 	 91-92		Figure	24:	A	pulse-chase	of	APOL1	expression	diminishes	cytotoxicity	 	 106		Figure	25:	The	ESCRT-III	mediated	wound	healing	pathway	rescues	cells	from	APOL1	cytotoxicity.	Involvement	of	the	lysosomal	wound	healing	pathway	remains	inconclusive.	 	 	 	 	 	 	 	 	 	 109		Figure	26:	Proposed	model	of	ESCRT-III	prevention	of	APOL1	cytotoxicity	 110				
				
	
	
	
	
	
	
	
	
	
	 xii	
Abbreviations		
∆F/F0	-	(FluorescenceTimeX	-	FluorescenceTime0)/FluorescenceTime0	
ACD	-	Autophagic	Cell	Death	
ALG2	-	Apoptosis-Linked	Gene	2	
ALIX	-	ALG-2	Interacting	Protein	
APOAI	-	Apolipoprotein	A-I	
APOL	-	Apolipoprotein	L-1-6	
BH3	-	Beclin-homology	domain	3	
cDNA	-	Complementary	DNA	
CHMP4B	-	Charged	Multivesicular	Body	Protein	4B	
CHO	-	Chinese	Hamster	Ovary	Cells	
CKD	-	Chronic	Kidney	Disease	
COPI	or	II	-	Coatomer	Protein	complex	
cRNA	-	Complementary	RNA	
DLD1	-	Human	Colorectal	Cancer	Cell	Line	
DRAQ7	-	Deep	Red	Anthraquinone	7	
EGTA	-	ethylene	glycol-bis(β-aminoethyl	ether)-N,N,N',N'-tetraacetic	acid	
ER	-	Endoplasmic	reticulum	
ER-LAR-GECO	-	Endoplasmic	Reticulum	LAR-GECO	(ER	localized	genetically	encoded	Ca2+	indicator)	
EREV	-	Reversal	Potential	
ESCRT-III	-	Endosomal	Sorting	Complexes	Required	for	Transport	
ESKD	-	End	Stage	Kidney	Disease	
	 xiii	
FOV	-	Field	of	View	
FSGS	-	Focal	Segmental	Glomerulosclerosis	
FT293	-	FlpIn	TREX293	Cells	(Stably	transfected	and	tet-inducible.	Distinguished	from	TREX293	because	of	single	recombination	site	for	cDNA)		
GAPDH	-	Glyceraldehyde	3-Phosphate	Dehydrogenase	
GCaMP	-	GFP,	Calmodulin,	and	M13	Peptide	(6f)	
Hb	-	Hemoglobin	
HDL	-	High	Density	Lipoprotein	
HEK293	-	Human	Embryonic	Kidney	Cells	293	
HGD	-	Hydrodynamic	Gene	Delivery	
Hp	-	Haptoglobin	
HpHb	-	Haptoglobin	-	Hemoglobin	Complex	
Hpr	-	Haptoglobin	Related	Protein	
IFN	-	Interferon	
IgM	-	Immunoglobulin	M	
KDEL	-	Lysine,	Aspartic	Acid,	Glutamic	Acid,	Leucine	
KKXX	-	Lysine,	Aspartic	Acid,	any	2	extra	amino	acids	
LDH	-	Lactate	Dehydrogenase	
Mcl-1	-	Myeloid	Leukemia	1	
MEFs	-	Mouse	Embryonic	Fibroblasts	
MTS	-	3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium	
NLRP3	-	NLR	Family	Pyrin	Domain	Containing	3	
	 xiv	
NRK	-	Normal	Rat	Kidney	Cells	
p38	MAPK	-	p38	Mitogen-Activated	Protein	Kinases	
PFN	-	Perforin	
PFT	-	Pore-Forming	Toxin	
PM	-	Plasma	Membrane	
rAPOL1	-	Recombinant	APOL1	
RT	-	Room	temperature	
RUSH	-	Retention	Using	Selective	Hooks	
SBP	–	Streptavidin	Binding	Peptide	
SERCA	-	Sacroendoplasmic	Reticular	Ca2+	ATPase	
SLO	-	Streptolysin	O	
SP	-	Signal	Peptide	
SRA	-	Serum	Resistance	Associated	(Protein)	
SytVII	-	Synaptotagmin	VII	
T.b.		-	Trypanosoma	brucei	
TbHpHbR	–	Trypanosoma	brucei	Haptoglobin	Hemoglobin	Receptor	
TgsGP	-	Trypanosoma	gambiense	Specific	Gene	
TLF	-	Trypanosome	Lytic	Factor	1	or	2	
VAMP8	-	Vesicle	Associated	Membrane	Protein	8	
Vps4b	-	Vacuolar	Protein	Sorting	4b	(DN	=	Dominant	Negative)	
VSG	-	Variant	Surface	Glycoprotein					
	 1	
Background	
The	APOL	Gene	Family	
	 Apolipoprotein	L-1	(APOL1)	is	a	primate-specific	innate	immunity	gene	(Smith	and	Malik,	2009)	that	encodes	for	a	cation	channel	(del	Pilar	Molina-Portela	et	al.,	2005;	Thomson	and	Finkelstein,	2015).		It	is	part	of	the	rapidly	evolving	APOL	family,	containing	genes	APOL1-6,	which	reside	in	a	620kb	region	of	chromosome.	
APOL5-6	are	the	oldest	genes	in	the	family,	while	APOL1-4	are	primate-specific	and	arose	through	duplications	beginning	~33	million	years	ago.	The	region	has	undergone	heavy	positive	selection	during	primate	evolution	(Smith	and	Malik,	2009),	and	as	all	APOL	genes	are	induced	by	pro-inflammatory	cytokines	(Liao	et	al.,	2011;	Nichols	et	al.,	2015;	Schoggins	et	al.,	2014;	Zhaorigetu	et	al.,	2011)	,this	signifies	a	role	in	the	host	immune	system.	Indeed,	the	pro-apoptotic	APOL6			provides	immunity	against	Poliovirus	(Schoggins	et	al.,	2014),	and	APOL1	is	associated	with	lowering	HIV	infectivity	in	HEK293	cells	(Taylor	et	al.,	2014).	It	is	suspected	that	the	immunity	provided	by	these	genes	is	due	to	their	roles	in	promoting	or	inhibiting	programmed	cell	death	pathways	(Liao	et	al.,	2011;	Wan	et	al.,	2008;	Zhaorigetu	et	al.,	2011),	however	this	remains	controversial.	Importantly,	
APOL1	provides	immunity	independent	of	programmed	cell	death	pathways.			
	
APOL1	Provides	Immunity	Against	African	Trypanosomes		 APOL1	is	unique	among	the	APOL	family	members	because	the	major	splice	isoform	encodes	a	signal	peptide	for	protein	secretion	(Monajemi	et	al.,	2002).	Upon	
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secretion,	APOL1	associates	with	specialized	high-density	lipoprotein	(HDL)	particles	termed	trypanosome	lytic	factors	(TLF)	1	and	2	(Barth,	1989;	Lugli	et	al.,	2004;	Raper	et	al.,	1999).	The	structure	of	the	APOL1	associated	with	HDL	particles	is	unknown,	but	based	on	other	lipoproteins	it	is	presumed	that	the	amphipathic	helices	are	embedded	into	the	face	of	the	phospholipids	that	form	the	surface	of	the	HDL	and	that	each	APOL1	is	a	monomer.	TLFs	continuously	circulate	within	the	bloodstream	and	make	up	approximately	1%	of	total	HDLs.	TLF1	and	2	also	contain	proteins	apolipoprotein	A-I	(APOAI),	the	essential	structural	component	for	all	HDLs,	and	haptoglobin-related	protein	(Hpr).	Additionally,	TLF2	is	associated	with	an	immunoglobulin	M	(IgM)	molecule	(Lugli	et	al.,	2004;	Raper	et	al.,	1999).	Circulating	continuously	within	the	bloodstream,	TLFs	provide	an	innate	defense	against	leishmania	(Samanovic	et	al.,	2009)	and	African	trypanosome	parasites	(Hager	et	al.,	1994),	of	which	Trypanosoma	brucei	is	the	most	studied.			 African	trypanosomes	are	single-celled,	flagellated,	protozoan	parasites	that	have	a	two-species	life	cycle	between	mammals	and	the	tsetse	fly	vector.	After	delivery	via	the	tsetse	fly,	trypanosomes	circulate	in	the	bloodstream	of	the	mammalian	host	and	can	eventually	cross	the	blood-brain	barrier	causing	sleeping	sickness,	which	is	fatal.	They	evade	the	adaptive	immune	system	due	to	a	dense	coat	of	variant	surface	glycoprotein	(VSG)	that	surrounds	their	plasma	membrane	(PM),	blocking	access	to	other	epitopes	(Barry	and	McCulloch,	2001).	One	VSG	gene	is	expressed	at	a	time,	and	is	switched	stochastically	every	1/1000	divisions	(Turner,	1997).	As	the	adaptive	immune	system	responds	to	the	first	VSG	detected,	several	other	populations	will	have	arisen	expressing	other	VSGs	(Mugnier	et	al.,	2015),	in	a	
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perpetual	game	of	cat	and	mouse	in	which	the	trypanosomes	almost	always	win.	However,	humans	and	some	primates	(Lugli	et	al.,	2004)	are	resistant	to	nearly	all	species	of	African	trypanosome	due	to	the	action	of	the	innate	immunity	complexes	of	TLF	(Hajduk	et	al.,	1989;	Vanhamme	et	al.,	2003).		 TLF	immunity	against	trypanosomes	is	due	to	uptake	of	the	complex	by	the	parasite	(Hager	et	al.,	1994;	Hajduk	et	al.,	1989).	Trypanosomes	are	heme-auxotrophs	(Berriman	et	al.,	2005;	Kořený	et	al.,	2010)	and	therefore	scavenge	it	from	the	mammalian	host.	Free	hemoglobin	(Hb)	is	sequestered	by	haptoglobin	(Hp)	(Andersen	et	al.,	2012)	to	prevent	oxidative	damage,	and	is	recognized	by	the	host	CD163	receptor	for	bloodstream	clearance	(Nielsen	et	al.,	2006;	Schaer	et	al.,	2006).	Trypanosomes	express	a	very	different	haptoglobin-hemoglobin	receptor	(HpHbR)	to	endocytose	these	Hp-Hb	complexes	(Higgins	et	al.,	2013;	Stødkilde	et	al.,	2014).	Taking	advantage	of	this,	the	TLF-specific	Hpr	also	binds	Hb	and	is	recognized	by	HpHbR	(Drain	et	al.,	2001),	but	not	CD163	(Drain	et	al.,	2001;	Nielsen	et	al.,	2006).	This	allows	for	endocytosis	of	TLF1	by	the	parasite,	though	this	endocytosis	can	be	inhibited	by	normal	levels	(0.25-1	mg/ml)	of	HpHb	(Smith	and	Hajduk,	1995).	Entry	of	TLF2	occurs	independent	of	HpHbR,	as	unlike	TLF1	it	can	lyse	HpHbR-null	parasites	(Vanhollebeke	et	al.,	2008).	However,	the	“receptor”	for	the	enhanced	uptake	of	TLF2	remains	undefined.	Once	endocytosed,	both	TLFs	deliver	the	killing	blow	of	APOL1.		
APOL1	Kills	Trypanosomes	by	Forming	pH-gated	Cation-Selective	
Channels	
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	 Trypanolysis	by	TLF	is	due	to	APOL1	and	its	channel	forming	properties	(Thomson	and	Finkelstein,	2015).	Contention	between	whether	APOL1	or	Hpr	were	the	lytic	component	of	TLF	was	settled	with	the	discovery	of	a	human	patient	that	was	infected	with	T.	evansi,	which	normally	infects	domesticated	mammals.	The	patient	had	frameshift	mutations	in	both	APOL1	alleles,	and	his	non-trypanolytic	serum	could	be	restored	with	addition	of	r	recombinant	APOL1	(rAPOL1)	(Vanhollebeke	et	al.,	2006).		Additionally,	mice	infected	with	T.	brucei	could	be	protected	by	hydrodynamic	gene	delivery	(HGD)	of	an	APOL1-containing	plasmid,	which	would	be	expressed	in	the	liver	and	secreted	onto	HDLs.	Expression	of	Hpr	did	not	protect	mice	from	infection,	leading	to	the	conclusion	that	APOL1	is	the	lytic	component	of	TLF	(Molina-Portela	et	al.,	2008).			 APOL1	channel	formation	is	a	two-step	process:	First,	acidification	is	required	for	an	irreversible	insertion	into	membrane,	followed	by	neutralization	for	channel	opening.	Incubation	of	recombinant	APOL1	(rAPOL1)	in	a	planar	lipid	bilayer	at	neutral	pH	did	not	lead	to	channel	formation	and	allowed	rAPOL1	to	be	perfused	away,	indicating	weak	or	no	association	with	the	membrane	(Thomson	and	Finkelstein,	2015).	However,	incubation	at	pH	5.5	led	to	the	recording	of	a	small	current	with	both	rAPOL1	and	TLF1	(del	Pilar	Molina-Portela	et	al.,	2005;	Thomson	and	Finkelstein,	2015).	This	current	was	thought	to	represent	APOL1	channel	activity,	however	subsequent	experimentation	with	rAPOL1	revealed	that	this	was	likely	due	to	membrane	insertion,	which	caused	a	small	ion	leak	(1-2pA).	Neutralization	of	rAPOL1	after	acidic	insertion	caused	a	100-200-fold	increase	in	
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current,	indicating	that	the	channel	is	pH-gated	and	in	an	open	state	in	a	neutral	environment.			 The	requirement	for	pre-acidification	is	likely	to	drive	oligomerization.	The	C-terminus	of	APOL1	contains	a	leucine	zipper	domain	(Vanhollebeke	and	Pays,	2006)	that	may	drive	homo-oligomerization	(Baisamy	et	al.,	2005).	This	region	contains	an	isoelectric	point	(pI)	of	4.5-5.0,	indicating	that	acidification	could	allow	for	irreversible	membrane	insertion	due	to	neutralization	of	the	charges.	In	contrast,	baboon	APOL1	does	not	require	acidification	for	channel	formation	(Thomson,	2018),	and	the	pI	of	the	C-terminus	is	approximately	9.0-9.5	(Thomson	et	al.,	2009).	This	suggests	that	for	channel	assembly,	the	acidification	of	human	APOL1	drives	membrane	insertion	of	the	C-terminus.		 Ion	selectivity	experiments	revealed	that	the	APOL1	channel	is	selective	for	monovalent	cations	Na+	and	K+,	but	not	for	Cl-	(Thomson	and	Finkelstein,	2015).	Delivery	of	APOL1	into	trypanosomes	causes	an	influx	of	Na+	(del	Pilar	Molina-Portela	et	al.,	2005).	In	response	to	an	increase	of	positive	charges	in	the	cytoplasm,	and	possible	membrane	depolarization,	a	K+	efflux	occurs.	This	drives	both	an	influx	of	Cl-	and	water,	the	latter	due	to	the	increased	amount	of	solutes	in	the	cytoplasm,	and	leads	to	osmotic	swelling	and	lysis	(Rifkin,	1984).	Replacement	of	Na+	in	the	media	with	larger,	APOL1-impermeable	cations	such	as	choline,	led	to	partial	rescue	of	trypanosome	lysis	from	TLF	(del	Pilar	Molina-Portela	et	al.,	2005).	Furthermore,	incubation	of	trypanosomes	with	osmotically	active	sucrose	delayed	lysis	by	human	serum	(Rifkin,	1984).	APOL1	channel	formation	also	requires	acidification	in	trypanosomes,	as	pre-treatment	with	weak	bases	(Hager	et	al.,	1994;	Thomson	and	
	 6	
Finkelstein,	2015)	or	RNAi	knockdown	of	the	vacuolar-ATPase	(Currier	et	al.,	2018;	Lecordier	et	al.,	2014)	blocked	or	diminished	the	lytic	activity	of	TLF,	respectively.	These	data	lead	to	a	proposed	model	of	trypanolysis	wherein	APOL1	(within	TLF)	is	acidified	after	endocytosis,	allowing	for	membrane	insertion,	followed	by	recycling	to	the	PM	where	the	cation	selective	channel	opens.	This	model	is	contentious,	however,	as	others	have	proposed	the	lysosome	or	the	mitochondria	as	the	site	of	APOL1	trypanolytic	activity.		(Perez-Morga	et	al.,	2005;	Vanwalleghem	et	al.,	2015)	Importantly,	studies	providing	these	alternative	hypotheses	have	performed	their	experiments	with	rAPOL1,	which	does	not	occur	naturally.	A	recent	RNAi	screen	in	trypanosomes	that	probed	for	genes	that	affected	trypanosome	survival	in	response	to	APOL1	discovered	that	treatment	with	TLF1	and	rAPOL1	lyse	trypanosomes	via	different	mechanisms.	Chiefly,	the	kinesin	required	for	rAPOL1	toxicity	linked	to	the	mitochondria	had	little	to	no	effect	on	the	lytic	activity	of	the	physiologically	relevant	TLF1	(Currier	et	al.,	2018).			
A	Molecular	Arms	Race	Between	Humans	and	Trypanosomes			 A	molecular	arms	race	has	led	to	the	evolution	of	human-infective	
Trypanosoma	brucei	rhodesiense	and	gambiense	parasites	that	overcome	APOL1-mediated	lysis.	T.b.	rhodesiense	is	a	zoonotic	parasite	found	in	Eastern	and	Southern	Africa	that	causes	an	acute	form	of	sleeping	sickness	in	humans.	It	is	differentiated	from	T.	brucei	by	the	presence	of	a	single	gene,	evolved	from	a	VSG,	termed	serum	resistance	associated	(SRA)	protein.	SRA	localizes	to	the	endosomes	and	lysosome	of	the	parasite	and	directly	binds	to	APOL1,	preventing	trypanolysis	(Perez-Morga	
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et	al.,	2005).	SRA	binds	to	the	C-terminus	of	APOL1	at	acidic	pH,	and	in	planar	lipid	bilayer	experiments	it	prevents	rAPOL1	channel	formation.	Within	bilayers	pre-treated	with	rSRA	at	pH	5.5,	addition	of	rAPOL1	still	leads	to	the	small,	initial	current,	signifying	insertion.	However,	upon	neutralization	not	only	is	there	no	channel	opening,	but	the	small	current	depicting	rAPOL1	insertion	is	lost	(Thomson	and	Finkelstein,	2015).	This	suggests	that	SRA	allows	for	initial	insertion	but	prevents	oligomerization,	which	is	likely	due	to	its	binding	of	the	leucine	zipper	domain	at	the	C-terminus	(Thomson	and	Finkelstein,	2015;	Zoll	et	al.,	2018).		Expression	of	SRA	in	TLF-susceptible	T.	brucei	leads	to	complete	resistance	(Vanhamme	et	al.,	2003).			 T.b.	gambiense	is	found	in	Central	and	Western	Africa	and	causes	the	chronic	form	of	sleeping	sickness.	It	accounts	for	over	90%	of	sleeping	sickness	cases	in	humans	(Simarro	et	al.,	2010)	and	utilizes	a	multi-pronged	approach	to	evade	TLF	lysis.	The	T.b.	gambiense	HpHbR	contains	a	single	amino	acid	change,	L210S,	that	greatly	reduces	binding	to	both	HpHb	and	HprHb.	Additionally,	T.b.	gambiense	contains	the	TgsGP	gene,	also	evolved	from	a	VSG,	that	is	proposed	to	stiffen	intracellular	membranes	and	prevent	APOL1	insertion	in	the	endo/lysosome	(Capewell	et	al.,	2013;	Uzureau	et	al.,	2013).	The	selective	pressure	from	these	parasites	is	thought	to	be	the	driving	force	behind	two	alleles	of	APOL1,	which	arose	2,000-10,000	years	ago	in	sub-Saharan	Africa,	that	provide	humans	with	at	least	partial	immunity	from	trypanosome	infection.				 The	recently	evolved	sub-Saharan	African	alleles	of	APOL1	are	G1,	which	contains	a	two	amino	acid	substitution	(S342G	and	I384M),	and	G2,	which	has	a	six	
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base	pair	deletion	that	removes	N388	and	Y389	(Genovese	et	al.,	2010).	For	both	alleles,	the	mutations	are	at	the	C-terminus,	either	in	the	last	predicted	transmembrane	or	leucine	zipper	domains.	The	leucine	zipper	mutations	occur	in	the	APOL1	region	that	binds	to	SRA	(Thomson	et	al.,	2014;	Vanhamme	et	al.,	2003;	Zoll	et	al.,	2018).	Surface	plasmon	resonance	using	C-terminal	peptides	of	APOL1	and	rSRA	revealed	that,	compared	to	wild-type	G0,	G1	and	G2	had	two	and	five-fold	reduced	binding,	respectively.	This	was	corroborated	by	HGD	in	mice	infected	with	
T.	brucei	overexpressing	SRA	(mimicking	T.	b	rhodesiense).	In	this	study,	empty	vector	and	G0	offered	no	protection,	G1	provided	partial	protection,	and	G2	offered	the	most	protection	to	the	infected	mice	(Thomson	et	al.,	2014).	In	a	small	epidemiological	study	of	T.b.	rhodesiense	and	gambiense	infected	patients,	however,	it	was	discovered	that	G1	offered	no	immunity	against	T.b.	rhodesiense.	This	is	not	unexpected	due	to	G1	having	only	a	modest	reduction	in	SRA	binding	and	offering	only	partial	protection	against	SRA-expressing	trypanosomes.	However,	G1	was	associated	with	asymptomatic	T.b.	gambiense	infection,	which	is	diagnosed	by	detection	of	trypanosomes	in	the	bloodstream	but	not	the	cerebrospinal	fluid,	indicating	that	the	parasites	could	not	cross	the	blood-brain	barrier.	The	mechanism	underlying	G1	immunity	from	sleeping	sickness	caused	by	T.	b.	gambiense	remains	unknown.	Surprisingly,	G2	was	linked	to	a	more	severe	patient	outcome	from	T.b.	
gambiense	infection.	As	expected,	however,	G2	was	associated	with	immunity	against	T.b.	rhodesiense,	consistent	with	the	aforementioned	in	vivo	and	in	vitro	experiments	(Cooper	et	al.,	2017).	The	immunity	imbued	by	G1	and	G2	come	at	a	price,	however,	as	both	alleles	are	strongly	associated	with	kidney	disease.			
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The	Casualties	of	War:	Newly	Evolved	APOL1	Alleles	Cause	Kidney	
Disease	
	 People	with	two	copies	of	G1	or	G2	have	a	significantly	increased	risk	of	developing	a	myriad	of	forms	of	non-diabetic	chronic	kidney	disease	(CKD)	(Genovese	et	al.,	2010).	The	APOL1	variants	are	thought	to	be	a	significant	factor	in	explaining	the	high	rate	of	CKD	in	African-Americans	(AAs),	and	extrapolation	of	patient	data	estimates	that	up	to	5	million	AAs	carry	the	risk	genotype	(Friedman	et	al.,	2011).	The	risk	genotypes	are	associated	with	AA	lifetime	risk	of	developing	focal	segmental	glomerulosclerosis	(FSGS)	increasing	from	0.8%	to	4.25%,	hypertension-associated	end	stage	kidney	disease	(HA-ESKD)	from	2.75	to	11%,	and	HIV-associated	nephropathy	(HIVAN),	when	the	infection	is	left	untreated,	from	10%	to	50%	(Dummer	et	al.,	2015;	Genovese	et	al.,	2010;	Kopp	et	al.,	2011;	Tzur	et	al.,	2010).	G1	and	G2	are	also	associated	with	sickle	cell	nephropathy,	lupus	nephritis,	and	aterionephroslcerosis	(Ashley‐Koch	et	al.,	2011;	Freedman	et	al.,	2014;	Lipkowitz	et	al.,	2013).	Importantly,	the	risk	genotype	also	causes	faster	progression	from	CKD	to	ESKD	(Parsa	et	al.,	2013).			 A	follow-up	study	on	kidney	function	was	performed	on	the	patient	lacking	functional	APOL1	as	well	as	50	fellow	villagers,	8	of	which	contained	a	single	null	APOL1	allele.	No	change	in	kidney	health	or	function	was	reported,	demonstrating	that	APOL1	is	not	required	for	normal	kidney	function	(Johnstone	et	al.,	2012),	and	also	suggests	that	while	the	disease	phenotype	is	inherited	recessively,	G1	and	G2	represent	gain	of	function	mutations.	This	is	supported	by	the	fact	that	APOL1	is	associated	with	various	forms	of	kidney	disease.	Additionally,	the	low	penetrance	of	
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the	disease	phenotype	suggests	that	environmental	triggers,	such	as	an	HIV	infection,	are	necessary	to	trigger	disease	(Langefeld	et	al.,	2018;	Lee	et	al.,	2012a)	Interestingly,	no	difference	between	G1	or	G2	homozygotes,	or	compound	heterozygotes,	has	been	reported	in	terms	of	disease	type	or	risk.	As	APOL1	continuously	circulates	in	the	bloodstream	as	part	of	TLF,	the	question	became	whether	extracellular	or	intracellular	APOL1	leads	to	disease.	
	
Intracellular	APOL1	Leads	to	Kidney	Disease		 Multiple	studies	aimed	at	discovering	the	source	of	APOL1	that	leads	to	kidney	disease	suggest	that	intracellular	APOL1	is	the	culprit.	Two	separate	retrospective	transplant	studies	compared	allograft	survival	in	patients,	with	knowledge	of	either	donor	or	recipient	APOL1	genotype.		They	discovered	that	kidneys	from	donors	with	two	risk	alleles	had	a	significantly	lower	rate	of	survival,	while	the	genotype	of	recipients	had	no	effect	(Lee	et	al.,	2012a;	Reeves-Daniel	et	al.,	2011).	Another	study	analyzed	circulating	levels	of	APOL1	and	its	variants	using	liquid	chromatography	mass	spectrometry	on	serum	samples	of	3,450	individuals.	They	reported	no	difference	in	APOL1	levels	in	patients	with	or	without	symptoms	of	kidney	disease	(Kozlitina	et	al.,	2016).	An	additional	study	reported	that	a	small	set	of	patients	developed	collapsing	FSGS	after	an	intense	4-12	month	course	of	interferon	(IFN)	treatment	(Markowitz	et	al.,	2010).	As	IFNs	stimulate	expression	of	
APOL1,	a	retrospective	study	genotyped	these	patients	and	discovered	that	all	of	them	carried	the	APOL1	risk	genotype	(Nichols	et	al.,	2015).	Taken	to	together	these	
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studies	support	the	hypothesis	that	APOL1	endogenous	to	the	kidney	is	the	cause	of	CKD,	and	that	upregulation	of	APOL1	can	lead	to	disease.			 A	large	portion	of	APOL1-associated	kidney	diseases	affect	the	podocyte,	which	are	epithelial	cells	that	facilitate	filtration	by	partially	forming	the	glomerular	basement	membrane,	as	well	as	creating	the	final	barrier	of	filtration	by	interlocking	their	foot	processes	around	the	capillaries	of	the	glomerulus.	Analysis	of	human	tissues	samples	revealed	expression	of	APOL1	mRNA	in	several	tissues	types,	including	the	kidney	(Duchateau	et	al.,	2001;	Monajemi	et	al.,	2002).	Additionally,	immunohistochemistry	of	kidney	biopsies	revealed	APOL1	protein	expression	within	podocytes	(Ma	et	al.,	2014;	Madhavan	et	al.,	2011).	In	culture,	podocytes	express	low	levels	of	APOL1	mRNA	that	increases	up	to	ten-fold	upon	stimulation	with	IFN,	and	transient	overexpression	of	G1	and	G2	in	these	cells	is	highly	cytotoxic	(Nichols	et	al.,	2015).	These	data	have	led	to	the	study	of	APOL1	and	disease	in	cell	culture.			 G1	and	G2	are	cytotoxic	to	several	different	cell	types	when	overexpressed,	including	podocytes	(Cheng	et	al.,	2015;	Heneghan	et	al.,	2015;	Lan	et	al.,	2014;	Olabisi	et	al.,	2016).	G0	is	also	cytotoxic	in	transient	overexpression	systems,	however	significantly	less	so	than	G1	or	G2	(Lan	et	al.,	2014).	APOL1	cytotoxicity	is	characterized	by	cell	swelling	followed	by	lysis	(Olabisi	et	al.,	2016),	a	phenotype	similar	to	that	seen	in	TLF	or	human	serum	treated	trypanosomes	(Rifkin,	1984).	The	mechanism	behind	APOL1-mediated	cell	death	remains	highly	controversial,	with	many	cell	death	pathways	implicated.	We	aimed	to	elucidate	the	mechanism	by	
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which	APOL1	is	cytotoxic	to	cells,	and	began	by	evaluating	the	claim	that	APOL1	kills	by	activating	autophagy	(Wan	et	al.,	2008).			
APOL1	and	Autophagy	
	 Autophagy	is	the	process	by	which	cells	can	recycle	organelles	and	cytoplasmic	material,	a	process	that	is	markedly	increased	in	times	of	stress.	Activation	of	this	pathway	leads	to	formation	of	double-membrane	vesicles	termed	autophagosomes,	which	contain	cellular	material	and	are	fused	with	endosomes	and	lysosomes	for	degradation.	Autophagy	is	not	only	considered	a	pro-survival	process	in	times	of	nutrient	depletion,	but	also	essential	for	maintaining	cellular	homeostasis	(Colombo	and	Simon,	2009).	However,	a	sustained	increase	of	autophagic	turnover	is	thought	to	a	drive	autophagic	cell	death	(ACD),	a	unique	programmed	cell	death	pathway	in	which	the	cell	is	hypothesized	to	cannibalize	itself	(Levine	and	Kroemer,	2008).	Autophagy	is	regulated	by	many	factors,	including	proteins	containing	a	Beclin-2	homology	(BH)	domain	(Maiuri	et	al.,	2007a),	a	domain	that	APOL1	is	proposed	to	contain	(Wan	et	al.,	2008).		 BH	domain	containing	proteins	regulate	apoptotic	cell	death,	and	have	recently	been	proposed	to	regulate	autophagy	as	well.	Beclin-1,	a	BH3	domain	containing	protein,	is	required	to	initiate	formation	of	pre-autophagosomal	structures,	and	is	negatively	regulated	by	its	interaction	with	Beclin-2	(Maiuri	et	al.,	2007b).	This	interaction	occurs	through	the	amphipathic	helix	of	the	BH3	domain	and	can	be	disrupted	by	other	BH3	containing	proteins	as	well	as	BH3	mimetic	compounds,	thereby	initiating	autophagy	(Maiuri	et	al.,	2007a).	As	APOL1	was	
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predicted	to	contain	a	single	BH3	domain,	and	its	overexpression	in	mammalian	cells	led	to	an	increase	in	autophagy,	it	was	proposed	that	APOL1	cytotoxicity	occurred	via	ACD	(Wan	et	al.,	2008).		 Deletion	of	the	predicted	BH3	domain	of	APOL1	completely	rescued	cells	from	its	cytotoxicity.	Treatment	with	chemical	inhibitors	of	autophagy,	such	as	wortmannin,	was	also	protective.	This	led	the	authors	to	propose	that	ACD	was	the	driver	of	APOL1-mediated	cell	death	(Wan	et	al.,	2008).	However,	we	were	skeptical	of	their	methods,	most	notably	the	deletion	of	the	9	amino	acid	BH3	domain,	which	we	hypothesized	was	deleterious	to	normal	protein	function.	Additionally,	whether	or	not	autophagy	drives	cell	death	as	often	as	proposed	is	controversial	as	the	mere	presence	of	autophagic	flux	during	cell	death	does	not	mean	that	it	is	the	cause	(Barth	et	al.,	2010;	Kroemer	and	Levine,	2008).	This	prompted	us	and	our	collaborators	to	further	investigate	the	link	between	APOL1	and	autophagy.			
The	Cytotoxicity	and	Cell	Death	Mechanisms	of	the	APOL	Family		 APOL	family	members	have	also	been	implicated	with	cytotoxicity	and	programmed	cell	death	pathways.	APOL2	and	6	are	predicted	to	contain	a	single	BH3	domain,	similar	to	that	of	APOL1	(Liao	et	al.,	2011;	Liu	et	al.,	2005).	Overexpression	of	APOL6	in	DLD1	cells	is	cytotoxic	and	leads	to	cleavage	of	caspases	8	and	9	and	release	of	cytochrome	c	into	the	cytosol,	implicating	apoptotic	cell	death	(Liu	et	al.,	2005).	Contrarily,	APOL2	was	proposed	to	prevent	apoptotic	cell	death	in	human	bronchial	epithelial	cells	that	were	stimulated	with	IFNγ	(Liao	et	al.,	2011).	However,	further	work	performed	in	HeLa	cells	indicated	no	role	for	APOL2	in	IFN-
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related	cell	death	or	apoptosis	(Galindo-Moreno	et	al.,	2014).	While	the	phenomenon	may	therefore	be	cell-type	specific,	the	role	of	APOL2	in	apoptosis	remains	unclear.	Finally,	purified	rAPOL3	kills	T.	brucei,	though	the	toxicity	does	not	seem	specific	to	trypanosomes,	as	rAPOL3	was	also	lethal	to	mice	when	injected	(Fontaine	et	al.,	2017).	These	data	indicate	the	APOL	gene	family	is	directly	involved	in	promoting	or	inhibiting	cytotoxicity	through	various	mechanisms.	We	aimed	to	further	investigate	the	cytotoxicity	of	the	APOL	family	members,	as	well	as	their	channel-forming	properties	and	associated	cell	death	pathways.			
Cytotoxicity	of	APOL1	Is	Linked	with	Multiple	Cell	Death	Pathways		 The	cytotoxicity	of	APOL1	has	been	associated	with	multiple	cell	death	pathways.	Transient	transduction	of	G1	and	G2,	and	to	a	lesser	extent	G0,	led	to	lysosomal	rupture	in	podocytes.	This	was	evidenced	by	release	of	cathepsin-L	into	the	cytosol	48h	after	transduction	(Lan	et	al.,	2014).	In	another	study,	overexpression	of	G1	and	G2	in	stably	transfected	HEK293	cells	led	to	upregulation	of	genes	involved	in	mitochondrial	function,	among	others.	Mitochondrial	respiration	rates	were	decreased	by	G1	and	G2	overexpression,	leading	the	authors	to	suggest	mitochondrial	dysfunction	as	the	driver	of	APOL1-mediated	cell	death	(Ma	et	al.,	2017).	Other	studies	have	also	suggested	apoptosis	in	rat	liver	cells	(Cheng	et	al.,	2015),	binding	to	and	activation	of	αvβ3	integrin	receptors	in	podocytes	(Hayek	et	al.,	2017),	or	the	impairment	of	vacuole	acidification	in	yeast	as	the	causes	of	APOL1	cytotoxicity	(Kruzel-Davila	et	al.,	2017).		
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	 Pyroptosis,	the	programmed	necrotic	cell	death	pathway	that	utilizes	inflammation-regulated	caspases	to	trigger	toxic	pore	formation	by	Gasdermin-D	(Liu	et	al.,	2016),	was	also	implicated	in	APOL1-mediated	cell	death.	Overexpression	of	G1	and	G2	in	HeLa	cells	led	to	the	cleavage	of	caspase-1	and	release	of	cytosolic	interleukin-1β,	hallmarks	for	pyroptosis.	Treatment	of	HEK293	cells	with	the	caspase-1	specific	inhibitor	Ac-YVAD-CHO	rescued	G1	and	G2	cytotoxicity	(Beckerman	et	al.,	2017).	However,	it	should	be	noted	that	HEK293	cells	lack	the	necessary	machinery	to	undergo	pyroptosis	(Bast	et	al.,	2014),	so	it	is	surprising	that	a	chemical	inhibitor	of	pyroptosis	is	protective	.	Finally,	the	same	study	generated	a	transgenic	mouse	that	utilized	doxycycline	controlled	expression	of	
APOL1	behind	a	podocyte-specific	promoter,	G1	and	G2	overexpression	led	to	increased	staining	of	pyroptosis-related	proteins,	most	notably	caspase-1,	in	the	glomerulus.	Taken	together,	the	authors	suggest	that	overexpression	of	G1	and	G2	activates	pyroptosis,	which	triggers	podocyte	cell	death	(Beckerman	et	al.,	2017).			 The	p38	MAPK	pathway	is	protective	against	pore-forming	toxins	(PFTs)	(Cancino-Rodezno	et	al.,	2010;	Porta	et	al.,	2011)	and	is	associated	with	APOL1	overexpression.	In	C.	elegans,	treatment	with	a	sub-lytic	dose	of	the	PFT	Cry5B	was	toxic	when	p38	MAPK	was	knocked	down.	Additionally,	baby	hamster	kidney	cells	were	more	susceptible	to	the	PFT	aerolysin	when	p38	MAPK	was	chemically	inhibited	with	SB203580	(Huffman	et	al.,	2004).	Overexpression	G1	and	G2	in	TREX293	cells,	a	stably	transfected	HEK293	cell	line,	also	activated	p38	MAPK	(Olabisi	et	al.,	2016).	Activation	of	this	pathway	was	linked	to	APOL1-mediated	K+	efflux	from	the	cell,	a	phenotype	that	has	been	observed	in	mammalian	cells	treated	
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with	various	PFTs	(Kloft	et	al.,	2009).	Culturing	TREX293	in	media	that	replaced	Na+	with	K+	inhibited	both	cytotoxicity	and	p38	MAPK	activation.	Surprisingly,	inhibition	of	p38	MAPK	with	SB203580	exacerbated,	rather	than	rescued,	the	cytotoxicity	of	G1	and	G2	(Olabisi	et	al.,	2016).		 This	lack	of	consensus	is	biologically	unsatisfying	and	motivated	us	to	search	for	a	common	trigger	for	these	phenomena.	Evidence	suggests	that	APOL1	leads	to	channel	formation	when	overexpressed	in	animal	cells	(Heneghan	et	al.,	2015;	O'Toole	et	al.,	2018;	Olabisi	et	al.,	2016),	mirroring	its	activity	in	trypanosomes.	As	PFTs	lead	to	similar	cellular	phenotypes	and	cell	death	pathways	as	G1	and	G2	overexpression	(Cancino-Rodezno	et	al.,	2010;	Porta	et	al.,	2011),	we	hypothesized	that	the	kidney	disease	variants	of	APOL1	act	in	the	same	vein	by	forming	cation-selective	channels	at	the	PM.			
APOL1	Channel	Formation	at	the	PM	
	 The	major	spliced	isoform	of	APOL1	encodes	a	signal	peptide	for	trafficking	along	the	secretory	pathway	(Monajemi	et	al.,	2002;	Nichols	et	al.,	2015).	The	secretory	pathway	is	initiated	by	translation	of	the	protein	in	the	endoplasmic	reticulum	(ER),	followed	by	trafficking	along	the	Golgi.	APOL1	does	not	contain	additional	trafficking	signals	and	likely	traffics	through	secretory	vesicles	or	recycling	endosomes	to	reach	the	PM.	Along	this	route,	the	pH	of	the	trans-Golgi	and	secretory	vesicles	is	approximately	6.0	and	5.7,	respectively	(Paroutis	et	al.,	2004),	a	pH	range	that	was	sufficient	for	rAPOL1	insertion	into	planar	lipid	bilayers	(Thomson	and	Finkelstein,	2015).	If	APOL1	is	able	to	insert	in	this	acidic	
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environment	then	the	channel	will	assemble	(oligomerize),	and	upon	delivery	to	the	neutral	environment	of	the	PM,	the	channel	will	open	and	allow	for	an	ion	flux	across	the	PM.			 Localization	studies	support	the	hypothesis	of	APOL1	channel	formation	at	the	PM.	Within	IFNγ-stimulated	podocytes,	90%-95%	of	endogenous	APOL1	is	localized	to	the	endoplasmic	reticulum	(ER),	with	the	remaining	APOL1	found	at	the	PM	(Scales	et	al.,	2017).	PM	localization	is	also	reported	when	APOL1	is	overexpressed	in	TREX293	cells	and	cRNA	injected	Xenopus	oocytes	(Heneghan	et	al.,	2015;	O'Toole	et	al.,	2018).	In	agreement	with	podocyte	study,	the	majority	of	overexpressed	APOL1	in	hepatocytes	resides	in	the	ER.		Importantly,	little	to	no	secretion	of	APOL1	is	detected	in	cell	culture	(Cheng	et	al.,	2015),	and	within	the	human	body	approximately	90%	of	circulating	APOL1	is	synthesized	in	the	liver	(Shukha	et	al.,	2016).	These	data	indicate	that,	while	APOL1	traffics	along	the	secretory	pathway,	it	may	have	a	function	at	the	PM	in	certain	cell	types.	Indeed,	immunohistochemistry	of	human	kidney	biopsies	revealed	robust	expression	of	APOL1	protein	within	the	glomerulus	in	cells	expressing	the	podocyte	markers	WT1	and	GLEPP1	(Ma	et	al.,	2014;	Madhavan	et	al.,	2011).	Additionally,	podocytes	in	culture	expressed	APOL1	mRNA	and	protein	(Nichols	et	al.,	2015;	Scales	et	al.,	2017).	It	is	possible	that	some	APOL1	protein	detected	in	podocytes	is	from	the	splice	isoforms	lacking	a	signal	peptide.	However,	at	basal	levels	only	mRNA	from	the	spliced	isoform	containing	the	signal	peptide	is	detected	in	culture,	and	upon	IFN	stimulation,	this	isoform	is	expressed	several	times	higher	than	the	intracellular	isoforms	(Nichols	et	al.,	2015).	These	data	demonstrate	that	APOL1	is	present	in	
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podocytes	and	localizes	to	the	ER	and	PM,	where	it	may	form	cation-selective	channels	in	the	PM.		 Overexpression	of	APOL1	elicits	a	current	across	the	PM.	This	was	detected	in	patch-clamped	TREX293	cells	and	Xenopus	oocytes	(Heneghan	et	al.,	2015;	O'Toole	et	al.,	2018).	Lowering	the	pH	below	6.0	inhibited	the	current,	consistent	with	the	properties	of	pH	gating	observed	with	rAPOL1	in	planar	lipid	bilayers	(Thomson	and	Finkelstein,	2015).	APOL1	also	led	to	Na+	influx,	K+	efflux,	and	cell	swelling	(O'Toole	et	al.,	2018;	Olabisi	et	al.,	2016),	events	that	occur	in	TLF	or	human	serum	treated	trypanosomes	(Rifkin,	1984)	and	that	suggest	formation	of	cation-selective	channels.	Interestingly,	in	oocytes	APOL1	also	led	to	the	intracellular	accumulation	of	45Ca2+	from	the	extracellular	environment	(Heneghan	et	al.,	2015).	As	Ca2+	is	a	potent	signaling	molecule,	we	were	interested	in	studying	what	effects	Ca2+	had	on	the	cytotoxicity	of	APOL1.			
Ca2+	Signaling	
	 Ca2+	regulates	many	signaling	pathways	and	cellular	processes.	In	order	to	facilitate	rapid	signaling,	free	Ca2+	in	the	cytosol	is	maintained	at	100-200nM,	while	extracellular	Ca2+	typically	ranges	from	1-3mM.	In	order	to	maintain	this	basal	level	of	Ca2+,	the	plasma	membrane	Ca2+	ATPase	(PMCA)	pump	as	well	as	Na+/Ca2+	and	Na+/Ca2+-K+	exchangers	transport	Ca2+	across	the	PM	(Clapham,	2007).	Increases	in	cytosolic	Ca2+	typically	occur	from	two	places:	Extracellularly	through	the	action	of	voltage	or	ligand	gated	Ca2+	channels	at	the	PM,	or	by	release	from	the	ER	via	activation	of	the	Ryanodine	or	IP3-binding	Ca2+	release	receptors	on	the	ER	
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membrane	(Prakriya	and	Lewis,	2015).	The	ubiquity	of	various	Ca2+	binding	and	adapter	proteins	throughout	the	cell	allows	for	small	increases	in	cytosolic	Ca2+	to	have	large,	localized	effects.		 The	ER	acts	as	a	Ca2+	store	and	typically	contains	100-800µM	Ca2+,	and	ER	Ca2+	release	is	integral	to	initiate	many	intracellular	inflammatory	and	signaling	pathways.	Once	Ca2+	is	released	from	the	ER,	the	stores	are	replenished	via	the	action	of	store-operated	Ca2+	channels	(SOC).	This	utilizes	the	luminal	Ca2+	sensor	STIM1,	which	then	binds	to	the	SOCs	Ora1	and	2	at	ER:PM	junctions,	facilitating	a	cytosolic	Ca2+	influx.	The	Ca2+	is	then	pumped	back	into	the	ER	via	the	sacroendoplasmic	reticular	Ca2+	ATPase	(SERCA).	In	addition	to	the	ER,	mitochondria	also	play	a	role	in	Ca2+	signaling	and	can	buffer	cytosolic	Ca2+(Prakriya	and	Lewis,	2015).	As	APOL1	leads	to	uptake	of	Ca2+	(Heneghan	et	al.,	2015),	it	may	affect	these	signaling	processes.			 Accumulation	of	intracellular	Ca2+	by	APOL1	can	have	large	effects	on	the	cell,	and	may	play	an	important	role	in	the	cell	death	mechanisms	that	APOL1	has	been	associated	with.	Indeed,	increased	intracellular	Ca2+	can	activate	the	NLRP3	inflammasome	complex	that	initiates	pyroptosis	(Lee	et	al.,	2012b).	Additionally,	the	mitochondria	can	act	as	a	Ca2+	sink	for	increasing	cytosolic	Ca2+	levels.	If	Ca2+	levels	persist,	the	mitochondria	may	become	overloaded,	leading	to	collapse	of	the	electrochemical	proton	gradient,	mitochondrial	swelling,	and	necrotic	cell	death	(Rizzuto	et	al.,	2012).	Ca2+	also	plays	an	important	role	in	apoptosis	(Pinton	et	al.,	2008).		
	 20	
	 Due	to	the	many	roles	Ca2+	has	within	the	cell,	we	were	motivated	to	study	whether	or	not	APOL1	leads	to	a	Ca2+	influx	in	mammalian	cells	and	what	effects,	if	any,	Ca2+	levels	have	on	APOL1	cytotoxicity.	Additionally,	we	set	out	to	elucidate	the	source	of	Ca2+,	and	whether	or	not	APOL1	itself	forms	channels	that	are	permeable	to	Ca2+.	Finally,	if	APOL1	indeed	forms	Ca2+-selective	channels	at	the	PM,	we	hypothesize	that	it	leads	to	the	activation	of	the	Ca2+-regulated	wound	healing	pathways.			
Ca2+	Activated	Wound	Healing	Pathways	Protect	Cells	From	PFTs	
		 There	are	two	independent	Ca2+	activated	wound	healing	pathways	within	a	cell	that	repair	the	PM;	Lysosomal	exocytosis	followed	by	endocytosis	of	the	lesion,	and	endosome	sorting	complexes	required	for	transport	(ESCRT)-III-mediated	membrane	shedding.	Both	of	these	pathways	remove	the	lesion	from	the	PM,	which	is	required	for	survival	against	PFTs.	The	influx	of	Ca2+	is	essential,	as	removal	or	chelation	of	extracellular	Ca2+	greatly	sensitizes	mammalian	cells	to	a	wide	range	of	PM	injuries,	from	the	PFT	streptolysin	O	(SLO)	to	UV-laser	(Idone	et	al.,	2008;	Jimenez	et	al.,	2014).		 The	lysosomal	wound	healing	pathway	is	initiated	by	an	influx	of	Ca2+	that	is	detected	by	the	lysosome	bound	synaptotagmin	VII	(SytVII).	Once	bound	to	Ca2+,	SytVII	facilitates	the	fusion	of	peripheral	lysosomes	with	the	PM	(Idone	et	al.,	2008;	Reddy	et	al.,	2001).	Release	of	the	lysosomal	enzyme	acid	sphingomyelinase	near	the	wound	site	remodels	the	affected	membrane	by	converting	sphingomyelin	on	the	outer	leaflet	of	the	PM	to	ceramide,	which	drives	tighter	membrane	packing	and	
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invagination.	Invaginated	membrane	is	then	endocytosed	via	caveolins	and	the	affected	membrane,	along	with	any	PFTs,	is	degraded	(Figure	1A)	(Tam	et	al.,	2010).				 ESCRT-III	buds	membrane	away	from	the	cytoplasm,	either	into	organelles	or	the	extracellular	environment	(Alonso	et	al.,	2016).	In	the	case	of	wound	healing,	the	ESCRT-III	components	are	recruited	to	the	site	of	Ca2+	influx	by	apoptosis-linked	gene	(ALG)-2,	which	contains	Ca2+	binding	domains,	and	ALG-2	interacting	protein	X	(ALIX).	Once	at	the	site,	the	ESCRT-III	components	interact	and	polymerize	to	drive	membrane	remodeling	and	budding	(Jimenez	et	al.,	2014;	Scheffer	et	al.,	2014).	In	order	for	the	complex	to	disassemble,	and	also	possibly	for	the	final	step	of	membrane	scission,	the	type-I	ATPase	vacuolar	protein	sorting	(Vps)	4	is	required	(Figure	1B)	(Alonso	et	al.,	2016).	Overexpression	of	a	dominant-negative	form	of	Vps4b,	which	is	incapable	of	ATP	hydrolysis	(Fujita	et	al.,	2003),	prevents	ESCRT-III-mediated	budding	and	sensitizes	cells	to	UV-laser	wounding(Jimenez	et	al.,	2014).	Interestingly,	APOL1	was	detected	in	ALIX-containing	microvesicles	when	overexpressed	in	HEK293	cells	(Taylor	et	al.,	2014),	suggesting	that	APOL1	activates	the	ESCRT-III	wound	healing	pathway.		 We	hypothesize	that	if	APOL1	directly	leads	to	an	influx	of	Ca2+	across	the	PM,	then	these	wound	healing	pathways	will	be	activated	to	promote	cell	survival	against	the	threat	of	APOL1	channel	formation.			
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Research	Questions	Chapter	1	
• Is	the	BH3	domain	of	APOL1	required	for	cytotoxicity	
• Is	deletion	of	the	9	amino	acid	BH3	domain	deleterious	to	APOL1	function	
• Is	autophagy	the	driver	of	APOL1-mediated	cell	death	
• What	other	members	of	the	APOL	gene	family	encode	cytotoxic	proteins,	and	via	what	mechanism	are	they	cytotoxic	Chapter	2	
• Does	APOL1	form	channels	that	are	permeable	to	Ca2+	
• What	effects,	if	any,	do	extracellular	Ca2+	levels	have	on	APOL1	cytotoxicity	
• Does	APOL1	lead	to	an	influx	of	Ca2+	
• If	APOL1	does	form	channels,	are	they	localized	to	the	PM	
• Why	is	G0	minimally	toxic	compared	to	G1	or	G2	Chapter	3	
• Does	APOL1	activate	the	lysosomal	or	ESCRT-III	wound	healing	pathways	when	overexpressed	
• Does	modulation	of	the	wound	healing	pathways	affect	cell	survival	against	the	cytotoxicity	of	APOL1									
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Materials	and	Methods	
	
Cloning	and	vector	construction			 APOL1-G0	(BC143038.1)	cDNA	in	the	PRG977	plasmid	(ubiquitin	promoter)	was	first	mutated	to	substitute	the	lysine	at	residue	150	to	glutamic	acid	(K150)	using	the	QuikChange	II	Mutagenesis	Kit	(Agilent	200523).	To	generate	G1,	two	rounds	of	mutagenesis	were	performed	(S342G,	I384M),	and	to	generate	G2,	N388	and	Y389	were	deleted.	cDNA	for	G0,	G1,	and	G2	were	inserted	into	the	pcDNA5/FRT/TO	(Thermo	V652020)	mammalian	expression	vector	between	the	EcoRV	and	XhoI	cut	sites.	APOL1	cDNA	was	also	inserted	into	the	Str-KDEL_SBP-EGFP-GPI	(RUSH)	vector	(Addgene	65293)	between	the	SbfI	and	XbaI	cut	sites,	removing	EGFP-GPI.		The	APOL1	cDNA	inserted	into	the	RUSH	contained	the	sequence	just	downstream	of	the	signal	peptide	cleavage	site	at	A27.	All	BH3	mutations	and	deletions,	KDEL	and	KKXX	signal	sequence	additions,	and	signal	peptide	deletion	were	performed	on	APOL1-G0	in	PRG977.			 We	received	plasmids	from	the	Harvard	PlasmID	Database	containing	APOL2	(Accession	number:	DQ893431.2,	Harvard	plasmid	ID	number:	HsCD00045448),	APOL3	(NP_055164.1,	HsCD00431226),	APOL4	(NM_145660.2,	HsCD00431838),	APOL5	(NM_030642.1,	HsCD00431854),	and	APOL6	(NM_030641.3,	HsCD00073674).	APOL2-6	cDNA	were	cloned	into	PRG977	between	the	XbaI	and	EcoRI	I	cut	sites.	The	putative	signal	peptide	of	APOL4	was	removed	by	PCR	of	the	original	cDNA	with	a	new	forward	primer.	In	order	to	tag	N-terminally	tag	APOL1-6,	G-blocks	(custom	designed	double	stranded	DNA)	were	ordered	from	IDT	containing	either	a	Myc-tag	or	3xFLAG	tag	with	a	2xGGSGG	linker	and	inserted	into	
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PRG977	between	the	XbaI	and	XhoI	cut	sites,	placing	them	upstream	of	the	APOL	cDNA.	For	APOL1,	G-blocks	were	ordered	with	the	APOL1	signal	peptide	sequence	followed	by	the	tag,	and	the	rest	of	the	APOL1	cDNA	was	inserted	just	downstream	of	the	tag.	Once	the	4	new	tagged	PRG977	vectors	were	generated	(Myc,	3xFLAG,	APOL1	signal	peptide	Myc,	APOL1	signal	peptide	3xFLAG),	cDNA	of	the	APOLs	was	inserted	between	the	XbaI	and	EcoRI	cut	sites.	Each	APOL	cDNA	was	tagged	with	Myc	and	3xFLAG.				 The	multi-cloning	site	of	PRG977	was	converted	to	contain	unique	cut	sites	NdeI,	PciI,	NheI,	and	NsiI.	This	was	performed	with	5’	phosphorylated	primers	that	contained	the	new	MCS	sequences	split	between	two	primers.	The	primers	annealed	to	PRG977	on	either	side	of	the	original	multi-cloning	site.	Around	the	world	PCR	was	performed	followed	by	ligation.	Next,	the	ubiquitin	promoter	was	replaced	with	a	CMV	promoter	from	the	pCMVTnT	vector	(Promega).	The	ubiquitin	promoter	from	PRG977	was	cut	out	using	the	KpnI	and	SalI	restriction	enzymes,	and	CMV	was	inserted	in	its	place.	Human	Vp4sb	cDNA	was	ordered	from	the	DNASU	Plasmid	Repository	(DNASU	number:	HsCD00295797)	and	cloned	into	PRG2	between	the	PciI	and	NsiI	cut	sites.	The	E235Q	mutation	for	Vps4bDN	was	generated	via	mutagenesis.		
Primer	list		Forward	primers	listed	first		APOL1-G0	K150E	Mutagenesis	5’	TGAAAGAGTTTCCTCGGTTGAAAAGTGAGCTTGAGGATAAC	3’	5’	GTTATCCTCAAGCTCACTTTTCAACCGAGGAAACTCTTTCA	3’			APOL1-G0	E150	Conversion	to	G1	Mutagenesis	(2	rounds)	Round	1	S342G	5’	CGGATGTGGCCCCTGTAGGCTTCTTTCTTGTG	3’			
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5’	CACAAGAAAGAAGCCTACAGGGGCCACATCCG	3’			Round	2	I384M	5’	GGAGCTGGAGGAGAAGCTAAACATGCTCAACAATAATTATAAGA	3’	5’	TCTTATAATTATTGTTGAGCATGTTTAGCTTCTCCTCCAGCTCC	3’			APOL1-G0	E150	Conversion	to	G2	Mutagenesis	5’	AGCTAAACATTCTCAACAATAAGATTCTGCAGGCGGAC	3’	5’	GTCCGCCTGCAGAATCTTATTGTTGAGAATGTTTAGCT	3’		APOL1	into	pcDNA5		5’	ATGATATCGCCACCATGGAGGGAGCTG	3’	5’	ATCTCGAGTCATCACAGTTCTTGGTCCGCCTG	3’		APOL1	into	Str-KDEL_SBP-EGFP-GPI	(RUSH)	5’	ATGCCCTGCAGGAGAGGAAGCTGGAGCGAGG	3’	5’	ATGCTCTAGACTATCACAGTTCTTGGTCCGCC	3		APOL1	BH3	deletion	5’	GAGGATAACATAAGAAGGAAGGTCCACAAAGGCACC	3’	5’	GGTGCCTTTGTGGACCTTCCTTCTTATGTTATCCTC	3’		APOL1	L158A	5’	GAGGATAACATAAGAAGGGCCCGTGCCCTTGCAGATC	3’	5’	GATCTGCAAGGGCACGGGCCCTTCTTATGTTATCCTC	3’		APOL1	R158A	5’	ATAACATAAGAAGGCTCGCTGCCCTTGCAGATGGGG	3’	5’	CCCCATCTGCAAGGGCAGCGAGCCTTCTTATGTTAT	3’		APOL1	D163A	5’	CCGTGCCCTTGCAGCTGGGGTTCAGAAGG	3’	5’	CCTTCTGAACCCCAGCTGCAAGGGCACGG	3’		APOL1	triple	mutant.	Add	L158A	and	R158A	to	D163A	5’	TGAGGATAACATAAGAAGGGCCGCTGCCCTTGCAGCTGGGG	3’		5’	CCCCAGCTGCAAGGGCAGCGGCCCTTCTTATGTTATCCTCA	3’			APOL1	KDEL	addition	5’	CAGGCGGACCAAGAACTGAAAGATGAACTGTGAGAATTCGAGATCTAG	3’	5’	CTAGATCTCGAATTCTCACAGTTCATCTTTCAGTTCTTGGTCCGCCTG	3’		APOL1	KKEL	mutagenesis	from	KDEL		5’	GCAGGCGGACCAAGAACTGAAAAAAGAACTGTGAGAATTC	3’	5’	GAATTCTCACAGTTCTTTTTTCAGTTCTTGGTCCGCCTGC	3’		
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APOL2	into	PRG977	5’	ATTCTAGAGCCACCATGAACCCAGAGAGCAGTATC	3’	5’	ACTGGAATTCTCACTATTGGTCTTGGCCTGGCTGCAG	3’		APOL3	into	PRG977	5’	AATCTAGAGCCACCATGGACTCAGAAAAGAAACGCTTTAC	3’	5’	GATCGAATTCTCATCAGTGGGTATGGCATGGATTCAGAC	3’		APOL4	into	PRG977	5’	AATCTAGAGCCACCATGGAGGGAGCTGC	3’	5’	GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG	3’		APOL5	into	PRG977	5’	AATCTAGAGCCACCATGCCATGTGGCAAAC	3’	5’	GATCGAATTCTCATTATTGTCGGTGTCTTCCCGGG	3’		APOL6	into	PRG977	5’	AATCTAGAGCCACCATGGACAACCAGGC	3’	5’	GATCGAATTCTCATCATGTAAACTGTACATACACACAGAC	3’		APOL1-G0	conversion	to	isoform	3,	signal	peptide	deletion	(Uniprot	O14791)	5’	CTGTCCTCTGCATCTGGGTGCAACAAAACGTTCC	3’	5’	GGAACGTTTTGTTGCACCCAGATGCAGAGGACAG	3’			APOL4	conversion	to	isoform	2,	signal	peptide	deletion	(Uniprot	Q9BPW4-2)	5’	GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG	3’	5’	GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG	3’		G-block	for	myc	tag	at	N-terminus	of	PRG977	5’GTCTCATCATTTTGGCAAAGAATTTATGCCTCGAGGCTAGCGCCACCATGGAACAAAAACTCATCTCAGAAGAGGATCTGGGTGGCAGCGGAGGTGGAGGCTCAGGTGGCTCTAGAATGCTTTGGGAACCCGGGTCTCT	3’	 	 	 	 	 	 		G-block	for	3xFLAG	tag	at	N-terminus	of	PRG977	5’TATGCCTCGAGGCTAGCGCCACCATGGACTACAAAGACCATGACGGTGATTATAAAGATCATGATATCGATTACAAGGATGACGATGACAAGGGTGGCAGCGGAGGTGGAGGCTCAGGTGGCTCTAGAATGCT	3’		G-block	for	APOL1-SP	followed	by	myc-tag	at	N-terminus	of	PRG977	(uppercase	denotes	APOL1	sequence)	5’	tatgcctcgaggctagcgccaccatgGAGGGAGCTGCTTTGCTGAGAGTCTCTGTCCTCTGCAT	CTGGATGAGTGCACTTTTCCTTGGTGTGGGAGTGAGGGCAatgcatgaacaaaaactcatctcagaagaggatctgggtggcagcggaggtggaggctcaggtggctctagaatgct	3’			
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G-block	for	APOL1-SP	followed	by	3xFLAG-tag	at	N-terminus	of	PRG977	(uppercase	denotes	APOL1	sequence)	5’	tatgcctcgaggctagcgccaccatgGAGGGAGCTGCTTTGCTGAGAGTCTCTGTCCTCTGCAT	CTGGATGAGTGCACTTTTCCTTGGTGTGGGAGTGAGGGCAatgcatgactacaaagaccatgacggtgattataaagatcatgatatcgattacaaggatgacgatgacaagggtggcagcggaggtggaggctcaggtggctctagaatgct	3’		APOL1	(downstream	of	signal	peptide	cleavage	site)	insertion	into	tagged	PRG977	5’	ATGCTCTAGAGAGGAAGCTGGAGCGAGG	5’	TCAACGAATTCTCACAGTTCTTGGTCCGCC	3’		APOL1	isoform	3	insertion	into	tagged	PRG977	5’ATGCTCTAGAGAGGGAGCTGCTTTGCTGAG	5’	TCAACGAATTCTCACAGTTCTTGGTCCGCC	3’		APOL2	insertion	into	tagged	PRG977	5’	ATGCTCTAGAAACCCAGAGAGCAGTATCTTTATTG	3’	5’	ACTGGAATTCTCACTATTGGTCTTGGCCTGGCTGCAG	3’		APOL3	insertion	into	tagged	PRG977	5’	ATGCTCTAGAGACTCAGAAAAGAAACGCTTTACTG	3’	5’	GATCGAATTCTCATCAGTGGGTATGGCATGGATTCAGAC	3’		APOL4	with	signal	peptide	insertion	into	tagged	PRG977	5’	ATGCTCTAGAGAGGGAGCTGCTTTGCTGAAAATC	3’	5’	GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG	3’		APOL4	without	signal	peptide	insertion	into	tagged	PRG977	5’ATGCTCTAGAGGATCCTGGGTGCAGCTCATC	3’	5’	GATCGAATTCTCATTAGCCTGCTTTTAGACTCTGATG	3’		APOL5	insertion	into	tagged	PRG977	5’ATGCTCTAGACCATGTGGCAAACAAGGAAATTTGC	3’	5’	GATCGAATTCTCATTATTGTCGGTGTCTTCCCGGG	3’		APOL6	insertion	into	tagged	PRG977	5’ATGCTCTAGAGACAACCAGGCGGAGAGAGAAAG	3’	5’	GATCGAATTCTCATCATGTAAACTGTACATACACACAGAC	3’		PRG977	conversion	to	PRG2	with	new	multi-cloning	site	5’	Phos	–	GGATGCATCCTAGTAACATGTTAATCAGCCATACCAC	3’	5’	Phos	–	CTGCTAGCCATGGACATATGAATTCTTTGCCAAAATGA	3’		CMV	promoter	into	PRG2	5’	ATGGTACCATCGATATAGTAATCAATTACGGGGTCATTAG	3’	5’	ACTGTCGACGATATCAGCTCTGCTTATATAGACCTCC	3’	
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Vps4b	into	PRG2-CMV	5’	ATGCACATGTGCCACCATGTCATCCACTTCGCCCAAC	3’	5’	ATGCATGCATCTATCAGCCTTCTTGACCAAAATCTTCTG	3’		Vps4bDN	E235Q	mutagenesis	5’	CCCTCCATTATCTTCATTGATCAAATTGATTCTCTCTGTGGTT	3’	5’	AACCACAGAGAGAATCAATTTGATCAATGAAGATAATGGAGGG	3’		
Generation	and	maintenance	of	FlpIn	TREX293	cells		 		 FlpIn	293	cells	from	Thermo	Scientific	were	maintained	in	DMEM	(Corning	10-017-CM)	with	Zeocin	(Gibco	R25001)	at	100µg/mL.	To	establish	a	FlpIn	TREX293	(FT293)	line,	cells	were	transfected	with	pcDNA6/Tet-Repressor	linearized	with	PciI.		The	media	was	replaced	the	day	after	transfection,	and	the	next	day	cells	were	trypsinized	and	seeded	at	approximately	20%	confluency.	4h	after	seeding,	the	media	was	replaced	to	that	containing	Zeocin	at	100µg/mL	and	blasticidin	(Gibco	R21001)	at	5µg/mL.	Media	was	changed	every	3-4	days	for	2-3	weeks	until	foci	formed.		Several	foci	were	picked,	expanded,	and	assayed	for	repressor	activity	and	expression	using	a	transient	transfection	of	APOL1	pcDNA5/FRT/TO.	A	single	clone	was	selected	and	expanded,	and	all	FT293-APOL1	cells	were	derived	from	this	same	clone.		 To	generate	single	copy	APOL1	cDNA	cell	lines,	the	Flp	recombinase	containing	vector	pOG44	(Thermo	V600520)	and	APOL1	pcDNA5/FRT/TO	were	co-transfected	at	a	9:1	ratio.	Cells	were	treated	as	before,	except	2	days	after	transfection	they	were	seeded	directly	into	media	containing	blasticidin	at	5µg/mL	and	the	new	antibiotic	Hygromycin	B	(Thermo	10687010)	at	150µg/mL.	2-3	weeks	after	transfection,	foci	were	pooled	and	polyclonal	cell	lines	for	APOL1	G0,	G1,	and	G2	were	expanded.	Cells	were	then	maintained	in	DMEM	+	10%	tet-free	FBS,	
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100µg/mL	Hygromycin	B,	5µg/mL	blasticidin,	and	1mM	sodium	pyruvate	(Sigma	P5280).		All	experiments	were	performed	in	the	absence	of	antibiotics.	APOL1	cDNA	expression	was	induced	in	these	cell	lines	with	the	addition	of	doxycycline	(Sigma	D9891)	to	the	media	at	various	concentrations.		
	 	
Cell	culture	and	transfections		 	 		 HEK293	cells	were	cultured	in	DMEM	+	10%	FBS,	CHO	cells	in	F12K	+	10%	FBS,	and	conditionally	immortalized	podocytes	(Saleem	et	al.,	2002)	in	RPMI1640	+	10%	FBS	and	ITS	(Gibco	41400045).	Podocytes	were	maintained	at	33C	on	Type-I	collagen-coated	plates.	For	experiments,	podocytes	were	moved	to	37C	for	5-7	days	to	allow	for	differentiation,	and	then	treated	for	24h	with	the	indicated	amounts	of	Interferon-γ	(R&D	Systems	285IF100).		 Cells	were	transfected	with	Lipofectamine	3000	prepared	in	Opti-MEM	as	per	the	manufacturer’s	instructions.		Plasmids	of	different	sizes	were	normalized	by	adding	the	same	pmol	amount	of	DNA	per	tube	for	co-transfections.	FT293	and	
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HEK293	cells	were	transfected	with	0.15uL	LF3000/well	in	a	96	well,	while	CHO	cells	were	transfected	with	0.3uL	LF3000/well.			 To	measure	the	effect	of	extracellular	Ca2+	on	APOL1	cytotoxicity,	experiments	with	FlpIn	TREX293	cells	were	performed	in	CaCl2	free	DMEM	(Gibco	21068-028)	supplemented	with	10%	FBS,	4mM	L-glutamine,	and	1mM	sodium	pyruvate,	and	then	with	or	without	the	addition	of	various	amounts	of	CaCl2	and	doxycycline.	To	chelate	extracellular	Ca2+,	cells	were	treated	with	EGTA	(Sigma	E3889).			 Acidification	of	cells	was	performed	in	HEK293	cells	transfected	with	RUSH-APOL1	plasmids.	1d	after	transfection,	cells	were	treated	with	or	without	80µM	biotin	for	4h	to	allow	for	APOL1	trafficking	to	the	PM.	Media	was	then	switched	to	fresh	DMEM	pH	7.4	or	DMEM	pH	5.5,	with	pH	lowered	by	addition	of	succinic	acid.	After	1h	of	this	treatment,	media	was	replaced	with	fresh	DMEM	pH	7.2	with	or	without	80µM	biotin.	24h	after	acid	treatment	cytotoxicity	was	measured.		 Cytotoxicity	was	measured	via	release	of	lactate	dehydrogenase	(LDH)	using	the	Cytotox	96	Non-Radioactive	Cytotoxicity	Assay	(Promega	G1781),	and	cell	viability	was	measured	using	the	CellTiter	96	Cell	Proliferation	Assay	(MTS	assay)	(Promega	G3580).	LDH	is	a	cytosolic	enzyme	that	is	only	released	from	cells	upon	large-scale	plasma	membrane	damage	or	cell	death.	The	LDH	assay	is	performed	on	cell	culture	media	from	treated	cells,	where	media	from	each	well	is	collected	and	assayed	for	enzymatic	activity	for	30min	at	RT.	Percent	LDH	release	is	directly	correlated	to	percent	cell	death	by	using	0	and	100%	cell	death	controls	(100%	cell	death	is	generated	by	treatment	with	0.9%	Triton-X	for	30min).	MTS	is	a	cell-
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permeant	viability	dye	that	is	reduced	by	metabolically	active	cells.	Measurement	of	MTS	is	performed	by	replacement	of	cell	culture	media	with	5	parts	fresh	media	and	1	part	MTS	reagent,	followed	by	incubation	for	1-4h	at	37C	and	then	measurement	in	a	new	assay	plate.	Percent	viability	is	calculated	by	using	untreated	cells	as	100%	alive	combined	with	a	media	only	control	for	background	subtraction.	Both	assays	have	a	colorimetric	readout	that	is	measured	by	absorbance	at	490nm.		
Lysate	collection	and	immunoblotting			 To	collect	lysates,	cells	were	washed	in	ice-cold	PBS	and	lysed	in	NP-40	lysis	buffer	(150mM	NaCl,	1.0%	NP-40,	1mM	EDTA,	50mM	Tris,	pH	8.0	)	with	HALT	protease	inhibitor	(Thermo	78430).	Cells	were	incubated	on	a	nutator	for	20min	at	4C,	then	spun	down	at	>14,000xg		for	15min	at	4C.	The	supernatant	was	collected	and	total	protein	content	was	quantified	with	the	DC	protein	assay	(Biorad	5000112).	Lysates	were	diluted	into	4xSDS	Laemmli	Buffer	with	2.5%	β-mercaptoethanol,	and	equal	amounts	of	protein	were	loaded	into	10%	Tris-Glycine	SDS	PAGE	gels	(Thermo	XP00100).	Gels	were	transferred	onto	PVDF	membrane	overnight	at	4C.	Membranes	were	blocked	for	1h	at	RT	with	LICOR	Odyssey	PBS	Blocking	Buffer	(927-40000),	then	incubated	with	primary	antibodies	in	LICOR	buffer	+	0.2%	Tween	at	room	temperature	for	1h	or	overnight	at	4C.	The	primary	antibodies	used	were	mouse	anti-APOL1	1:2,000	(Proteintech	66124-1-Ig),	rabbit	anti-APOL1	1:5,000	(Proteintech	11486-2-AP),	rabbit	anti-GAPDH	1:5,000	(Proteintech	10494-1-AP),	and	rabbit	anti-β-tubulin	1:1,000	(Proteintech	10094-1-AP).	Blots	were	washed	in	TBS/T.	Secondary	antibodies	were	incubated	in	the	
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LICOR	buffer	with	the	addition	of	0.2%	Tween	and	0.01%	SDS.	Secondary	antibodies	used	were	goat	anti-mouse	680RD	1:10,000	(LICOR	92568070),	and	donkey	anti-rabbit	800CW	1:10,000	(LICOR	925-32213).	After	washing	with	TBS/T,	two	final	washes	were	performed	with	plain	TBS,	and	then	blots	were	scanned	on	a	LICOR	Odyssey.		
Wound	healing	assays	
		 The	following	protocol	for	the	β-hexosaminidase	assay	was	adapted	from		(Rodríguez	et	al.,	1997).	β-hexosaminidase	is	a	lysosomal	enzyme	that	is	only	detected	in	cell	culture	media	after	cell	death	or	lysosomal	exocytosis.	It	is	therefore	a	marker	for	lysosomal	exocytosis	as	well	as	wound	repair.	Cells	were	grown	to	80-90%	confluency	and	media	was	changed	to	plain	DMEM	with	4mM	CaCl2	(serum	has	a	high	amount	of	β-hexosaminidase	activity).	Cells	were	then	treated	with	DMSO	or	10-40µM	Ca2+	ionophore	A23187	(Sigma	C7522)	for	5min	at	37C.	After	treatment,	media	was	immediately	collected	and	stored	on	ice	while	the	cells	were	washed	once	quickly	with	ice	cold	PBS	and	then	collected	in	NP-40	lysis	buffer	with	HALT	protease	inhibitor	and	moved	to	ice.	Media	was	spun	down	for	5min	>11,000	x	g	at	4C	and	supernatants	were	transferred	to	a	new	tube.	Lysates	were	incubated	on	a	nutator	for	a	minimum	of	15min	at	4C	and	then	spun	down	>14,000	x	g	for	15min	at	4C	and	supernatants	were	transferred	to	a	new	tube.	Before	the	assay,	a	6mM	stock	solution	of	substrate	was	made	in	1:1	acetone:water	(4-Methylumbelliferyl-N-acetyl-ß-D-glucosaminide	Bioworld	21530015-1).	To	analyze	the	media	from	each	well,	175uL	of	media	was	combined	with	175µL	sodium-citrate	buffer	(0.1M	dibasic	
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sodium	phosphate	and	0.05M	sodium	citrate,	pH	4.5)	and	50µL	of	substrate.	Lysates	were	diluted	1:5	in	water	and	assayed	in	the	same	manner.	Media	and	lysate	solutions	were	incubated	at	37C	for	a	minimum	of	15min	and	then	100µL	stop	solution	was	added	(2M	sodium	carbonate,	1.1M	glycine,	pH	10).	Samples	were	transferred	to	a	96	well	plate	and	analyzed	via	fluorescent	plate	reader	with	365nm	excitation	/	450nm	emission.	Percent	release	for	each	well	was	then	calculated.	In	parallel,	an	LDH	assay	was	performed	on	the	media.	For	longer	experiments,	10%	serum	in	the	media	is	best	avoided,	and	0.5-1%	BSA	can	be	used	as	a	substitute.		 	To	test	the	effects	of	ESCRT-III	wound	repair	on	APOL1	cytotoxicity,	HEK293	cells	were	co-transfected	with	RUSH-APOL1	and	Vps4b,	Vps4bDN,	or	empty	PRG2-CMV.	24h	after	transfection,	cells	were	treated	with	or	without	80µM	biotin.	48h	after	transfection,	cytotoxicity	and	cell	viability	were	measured.		 	
Cell	surface	protein	biotinylation	and	pull-down			 The	following	protocol	was	adapted	from	(Sharma	et	al.,	2012).	HEK293	cells	were	cultured	in	6cm	dishes	and	transfected	with	APOL1	PRG977	vectors	for	16h	before	biotinylation	of	cell	surface	proteins.	After	16h,	cells	were	washed	3	times	with	ice	cold	HBSS	and	then	HBSS	containing	0.5mg/mL	EZ-link	sulfo-NHS-LC-biotin	(Thermo	21335)	was	added	for	30min	at	4C.	The	solution	was	then	removed,	and	cells	were	washed	once	with	ice	cold	HBSS	and	then	quenched	with	0.1M	Tris-HCl	pH7.4	for	15min	at	4C.	Cells	were	then	lysed	in	ice	cold	RIPA	buffer	(150mM	sodium	chloride,	1.0%	NP-40	or	Triton	X-100,	0.5%	sodium	deoxycholate,	0.1%	SDS,	50mM	Tris,	pH	8.0)	with	HALT	protease	inhibitor.	Lysates	were	collected	by	scraping	and	
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incubated	on	a	nutator	for	1h	at	4C.	Lysates	were	then	spun	down	>13,000	x	g	at	4C	and	supernatants	were	collected	followed	by	quantification	of	total	protein	content.	800µg	total	protein	was	added	to	800uL	streptavidin	agarose	resin	+	storage	buffer	(Thermo	20349)	in	a	spin	column	(Thermo	89896).	The	resin	was	first	equilibrated	with	5	column	volumes	of	1:1	RIPA:PBS.	Lysates	were	incubated	with	the	resin	on	a	nutator	at	4C	for	1h	then	spun	down,	and	flow	through	was	collected.	Columns	were	then	washed	1	time	with	RIPA	buffer,	2	times	with	high	salt	buffer	(50mM	Tris-Cl	pH	8.0,	150mM	NaCl),	3	times	with	high	pH	buffer	(100mM	sodium	carbonate,	pH	10.5),	and	two	times	with	deionized	water.	Each	wash	contained	a	minimum	of	3	column	volumes	and	was	spun	down	at	1,000	x	g	for	2min.	High	salt	and	high	pH	washes	were	performed	for	a	minimum	of	5	or	10min	each,	respectively.	Resin	was	then	resuspended	in	200uL	2x	Laemmli	running	buffer	with	2.5%	β-mercaptoethanol	and	heated	to	95C	for	15min.	The	column	was	spun	down	and	the	running	buffer	was	collected	and	then	run	on	a	protein	gel	along	with	the	flow	through	for	immunoblotting.		 Future	experiments	should	be	performed	with	the	following	modifications.	Total	protein	input	should	be	increased	to	at	least	2mg	for	the	indicated	amount	of	streptavidin	resin.	Cell	surface	proteins	should	be	biotinylated	with	EZ-Link	Sulfo-NHS-SS-Biotin	(Thermo	21331),	which	is	thiol-cleavable,	allowing	for	milder	elution.	Finally,	heating	at	95C	will	cause	plasma	membrane	proteins	to	degrade	or	crash	out	of	solution,	including	the	Na+/K+	ATPase,	which	we	attempted	to	probe	for.	Instead,	elutions	should	be	performed	at	50C	for	30min	in	2x	Laemmli	buffer	with	β-mercaptoethanol	or	dithiothreitol.	
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Electrophysiology			 rAPOL1	was	purified	from	E.	coli	and	analyzed	in	planar	lipid	bilayers	as	previously	described	(Thomson	and	Finkelstein,	2015).	To	test	for	Ca2+	selectivity,	bilayers	were	formed	with	100mM	CaCl2,	0.5mM	EDTA,	5mM	K-HEPES,	pH	7.1	on	either	side.	The	cis	pH	was	then	adjusted	to	5.6	with	succinate	and	rAPOL1-G0	was	added.	After	rAPOL1	insertion,	the	cis	side	was	neutralized	with	1M	HEPES,	pH	7.5.	To	test	for	Ca2+	permeability	of	rAPOL1,	a	1.95	cis:trans	gradient	of	CaCl2	was	generated	by	adding	a	2mM	CaCl2	solution	to	the	cis	side.	To	determine	selectivity,	the	voltage	was	adjusted	until	the	reversal	potential	(ERev)	was	reached,	with	is	the	voltage	required	to	zero	the	current.	This	was	expanded	using	larger	cis:trans	gradients	and	was	performed	with	all	three	rAPOL1	variants.	The	ERev	of	an	ideal	Ca2+	channel	was	calculated	using	the	Nernst	equation.		
Live-cell	microscopy			 FlpIn	TREX	APOL1	cells	were	resuspended	in	Fluorobrite	DMEM	(Gibco	A18967-01)	with	10%	tet-free	FBS,	4mM	L-glutamine	(Gibco		25-030-081),	MEM	non-essential	amino	acids	(Gibco	11140-050),	and	1mM	sodium	pyruvate,	and	then	seeded	onto	black-walled,	optical	bottom	96	well	plates	(Thermo	165305)	that	were	freshly	coated	with	2.5µg/cm2	of	fibronectin	(Sigma	F1141).	The	day	after	seeding,	cells	were	transfected	with	pGP-CMVB-GCaMP6f	(Addgene	40755)	(Chen	et	al.,	2013)	using	Lipofectamine	3000.	6-12	hours	after	transfection	the	media	was	changed.	The	day	after	transfection,	APOL1	expressed	was	induced	with	50ng/mL	doxycycline	or	left	untreated.	3µM	DRAQ7	(Abcam	ab109202)	was	also	added	to	
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each	well	to	stain	dead	or	membrane-damaged	cells.	4-6	hours	after	induction,	cells	were	imaged	every	10	minutes	at	20x.		 For	RUSH	microscopy,	HEK293	and	CHO-K1	cells	were	seeded	onto	glass	bottom	96-well	(Grenier	655892)	or	24-well	(Cellvis	P24-1.5H-N)	plates	in	Fluorobrite	DMEM	as	listed	above	except	with	non-tet	free	FBS.	The	HEK	cells	were	seeded	onto	fibronectin	coated	wells,	whereas	the	CHO	were	grown	uncoated.	Two	days	prior	to	imaging,	cells	were	co-transfected	with	APOL1	RUSH	vectors	and	one	or	two	of	the	following	calcium	sensors:	GCaMP6f	and	CMV-ER-LAR-GECO1	(61244)	(Wu	et	al.,	2014).	The	media	was	changed	6-12h	after	transfection.	On	the	day	of	the	experiment,	80µM	biotin	(Sigma	B4639)	was	added	to	respective	wells	and	cells	were	then	imaged	every	5	minutes	at	10	or	20x.	Co-transfections	were	performed	using	1:1	ratio	for	both	plasmids,	while	triple	transfections	were	performed	using	a	2:1:1	ratio	of	RUSH-APOL1:GCaMP6f:ER-LAR-GECO.		 Sensor	validations	for	GCaMP6f	and	ER-LAR-GECO	were	performed	in	FT293	cells	the	day	after	transfection.	The	non-fluorescent	Ca2+	ionophore	4-bromo-A23187	(Sigma	B7272)	and	the	SERCA	pump	inhibitor	thapsigargin	(Thermo	T7458)	were	used.				
Immunofluorescence	staining		 		 CHO	cells	were	seeded	onto	glass	bottom,	96	well	plates	and	transfected	with	RUSH-G0.	2d	after	transfection,	cells	were	treated	with	or	without	80µM	biotin	for	2h.	For	cell	surface	immunostaining,	the	plate	was	moved	onto	water	ice	in	a	cold	room,	and	the	following	steps	were	all	performed	in	the	cold	room.	After	cooling	for	
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10min,	cells	were	washed	3	times	with	HBSS	+	Ca2+	+	Mg2+	+	1%	BSA	fraction	V,	and	blocked	in	the	same	solution	for	60min.	Blocking	solution	was	then	replaced	with	fresh	solution	containing	primary	antibodies	mouse	anti-APOL1	1:200	and	rabbit	anti-calnexin	(Stressgen	SPA-860)	1:200.	Cells	were	incubated	with	the	primary	antibodies	for	1h,	followed	by	2	quick	washes	and	then	4	x	5min	washes.	Cells	were	washed	1	time	with	plain	HBSS	and	then	fixed	with	2%	methanol-free	formaldehyde	(Thermo	28906)	for	20min.	Fixing	solution	was	removed	and	cells	were	washed	1	time	with	plain	HBSS	and	then	quenched	with	50mM	NH4Cl	for	20min	and	washed	once	more	with	HBSS.	The	following	steps	were	performed	at	room	temperature	and	away	from	light.	Cells	were	incubated	with	secondary	antibodies	anti-rabbit	Alexa	488	plus	1:500	(Thermo	A32731),	anti-mouse	Alexa	647	1:1,000	(Thermo	A21236),	and	Hoescht	33342	1:10,000	(Thermo	H3570)	in	blocking	solution	for	30min.	Cells	were	then	washed	2	times	quickly	followed	by	4	x	5min	washes.	100µL	of	2,2’-Thiodiethanol	(Sigma	166782)	was	then	added	to	each	well.	The	plate	was	covered	in	parafilm,	stored	at	4C	overnight	and	imaged	the	next	day.		 For	permeabilized	cell	immunofluorescence,	all	steps	were	performed	at	room	temperature.	The	cells	were	washed	3	times	and	then	fixed	and	quenched	as	described	above.	Cells	were	blocked	for	30min	with	the	addition	of	0.075%	saponin,	which	was	added	to	all	subsequent	solutions.	Cells	were	then	incubated	with	primary	and	secondary	antibodies,	washed,	and	stored	as	described	above.		 Future	experiments	should	modify	the	amount	of	Hoescht	33342	used	in	cell	surface	(non-permeabilized)	staining,	as	1:10,000	yielded	a	weak	nuclear	signal.	The	recommended	starting	concentration	is	1:1,000.	
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Microscopy	analysis		 		 To	measure	 the	 Ca2+	 kinetics	 in	 individual	 cells,	 video	 files	were	 imported	into	Fiji	and	analyzed	with	TrackMate	(Tinevez	et	al.,	2017).	Within	an	experiment,	the	same	parameters	for	spot	detection	and	track	linking	were	applied	to	each	file.	After	 automated	detection,	 files	were	manually	 curated	 to	 remove	 cells	 that	were	dead,	 overlapping,	 or	 those	 that	had	migrated	out	of	 the	 field	of	 view	 (FOV).	This	process	was	 applied	 to	 every	 cell	within	 the	 FOV.	 A	minimum	 of	 three	 files	 from	replicate	wells	was	 analyzed	 per	 condition	 and	 genotype.	 For	 each	 file,	 every	 cell	within	the	FOV	was	analyzed.	Cells	were	tracked	based	upon	the	fluorescence	of	the	Ca2+	sensor.	The	raw	data	was	then	exported	and	analyzed	with	R	to	determine	the	change	in	mean	fluorescence	intensity	for	each	cell	using	the	following	equation:		
(FluorescenceTime=X	–	FluroescenceTime=0)	/	FluroescenceTime=0	=	∆F/F0			where	F0	is	the	average	mean	fluorescence	of	the	first	3	timepoints	for	each	cell.				 In	order	to	quantify	the	amount	of	cells	that	exhibited	a	significant	increase	in	 intracellular	 Ca2+	 and	 differentiate	 them	 from	 cells	 undergoing	 transient	 Ca2+	signaling,	we	created	a	∆F/F0	threshold.	This	threshold	was	determined	by	manually	analyzing	 control	 cells	 (G0,	 uninduced	 or	 no	 biotin)	 for	 each	 experiment.	 The	threshold	was	dependent	on	the	cell	type,	objective,	and	sensor(s)	used.	In	order	for	a	cell	to	be	counted	as	positive	for	a	significant	Ca2+	influx,	the	∆F/F0	of	the	cell	had	to	be	above	the	threshold	for	a	minimum	of	5	timepoints.	 	
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	 For	 dual	 color	 tracking,	 the	 multi-channel	 tracking	 plug-in	 was	 used	 in	TrackMate,	which	allows	 for	 the	 tracking	of	 cells	 in	one	 channel	 (GCaMP6f)	while	collecting	data	from	all	other	channels	(DRAQ7,	ER-LAR-GECO).			 The	 following	TrackMate	 settings	 and	∆F/F0	thresholds	were	 used	 for	 live-cell	Ca2+	influx	experiments	with	GCaMP6f:		 										
			 Immunofluorescence	 analysis	 for	 APOL1	 signal	 at	 the	 cell	 surface	 was	performed	in	Fiji.	The	mean	fluorescence	intensity	of	the	entire	FOV	was	quantified	using	a	maximum	intensity	projection,	and	a	minimum	of	10	FOVs	were	analyzed	for	each	condition.	For	co-localization	of	APOL1	and	calnexin,	images	were	loaded	into	Icy	and	maximum	intensity	projections	were	generated	for	analysis.	Individual	cells	were	highlighted	and	then	the	spot	detector	tool	was	used	in	combination	with	the	tracking	program	to	calculate	percent	co-localization.			
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Microscopes	
		 For	live-cell	microscopy,	a	widefield	setup	was	used.	Live	imaging	was	performed	with	a	Ziess	Axio	Observer	with	470,	555,	or	625nm	LED	excitation	along	with	Zeiss	filter	cubes	38	(green),	20	(red),	and	50	(far-red).	Recording	was	performed	using	a	sCMOS	with	6.5µm	pixels	(Hamamatsu	Flash4.0v2).	Live	experiments	were	performed	within	an	incubation	chamber	at	37C	with	5%	CO2	and	humidity.		 For	immunofluorescence,	spinning	disk	confocal	microscopy	was	used.	A	Zeiss	Axio	Observer	was	fitted	with	a	Yokogawa	CSU-X1	spinning	disk	head.	Excitation	was	performed	with	405,	488,	561,	or	639nm	laser.	Recording	was	performed	using	a	back-thinned	EMCCD	camera	with	16µm	pixels	(Photometrics	Evolve512).		
In	vivo	mouse	challenge	and	HDL	purification	
	 In	 vivo	 mouse	 challenges	 were	 performed	 using	 20-25g	 female	 Swiss-Webster	 mice.	 Hydrodynamic	 gene	 delivery	 (HGD)	 of	 50µg	 of	 empty	 or	 APOL1	PRG977	 vectors	was	 performed	 by	 tail	 vein	 injection	 (27	 gauge	 syringe)	 using	 2-3mL	saline	 (10%	body	weight).	Two	days	after	 injection	each	mouse	was	 infected	with	5,000	Trypanosoma	brucei	427	parasites	via	intra-peritoneal	injection.	Every	2-3d,	20µL	tail	vein	blood	samples	were	collected	to	monitor	parasitemia.	Mice	were	euthanized	 if	 parasitemia	 reached	 1*10^9	 parasites/mL.	 All	 trypanosome	experiments	were	performed	in	a	biosafety	level	2	laboratory.		
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	 To	 analyze	 circulating	 APOL1	 levels,	mouse	 serum	was	 prepared	 from	 tail	bleed	samples	two	days	after	HGD	injection	by	centrifugation	with	serum	separators	(BD	365956)	at	6,000	x	g	for	1-2min.	To	analyze	APOL1	association	with	HDL,	mice	were	 injected	 via	HGD	 and	whole	 serum	was	 collected	 after	 2d.	Murine	HDL	was	purified	 as	 previously	 described	 (Molina-Portela	 et	 al.,	 2008).	 Serum	and	purified	HDL	were	diluted	1:40	 in	Laemmli	buffer	 and	 run	on	10%	Tris-glycine	SDS	PAGE	gels.	 Chemiluminescent	 immunoblots	were	performed	using	 anti-APOL1	1:10,000,	anti-APOA1	 1:10,000	 (Abcam	 ab20453),	 and	 anti-rabbit	 True	 Blot-HRP	 1:2,500	(Rockland	18-8816-33).														
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Chapter	1	
Assessing	the	Function	of	the	APOL1	BH3	Domain	and	the	
Cytotoxicity	of	the	APOL	Family	Members	
	
Introduction			 The	cytotoxicity	of	APOL1	has	been	linked	to	autophagic	cell	death	(ACD)	(Wan	et	al.,	2008).	Many	studies	have	reported	detection	of	autophagy	after	APOL1	overexpression	(Beckerman	et	al.,	2017;	O'Toole	et	al.,	2018;	Olabisi	et	al.,	2016).	However,	the	mere	presence	of	autophagic	turnover	occurring	during	cell	death	does	not	mean	that	it	is	the	cause	(Kroemer	and	Levine,	2008).	Autophagy	and	ACD	can	be	regulated	by	BH	domain	containing	proteins	(Maiuri	et	al.,	2007a),	and	in	
silico	prediction	revealed	that	APOL1	contains	a	single	BH3	domain	(Wan	et	al.,	2008).			 Deletion	of	the	APOL1-G0	BH3	domain	(APOL1.∆BH3)	completely	rescued	the	human	colon	cancer	DLD1	cells	from	APOL1	cytotoxicity,	as	did	treatment	with	chemical	autophagy	inhibitors	such	as	wortmannin.	Overexpression	of	APOL1	in	mouse	embryonic	fibroblasts	(MEFs)	that	had	autophagy	related	gene	(ATG)	5	knocked	out	were	partially	rescued	from	cytotoxicity	as	well	(Wan	et	al.,	2008).	These	data	suggested	ACD	as	a	mechanism	of	APOL1-mediated	cell	death.	However,	the	methods	used	left	results	open	to	an	alternative	interpretation.	Chiefly,	deletion	of	the	nine-amino	acid	sequence	representing	the	BH3	domain	was	likely	deleterious	to	normal	protein	function.	Rather	than	outright	deletion,	alanine	scanning	is	typically	used	to	modulate	BH	domain	function,	as	these	amphipathic	helices	directly	facilitate	protein:protein	interactions	(Day	et	al.,	2008).	Additionally,	
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cytotoxicity	in	MEFs	was	represented	with	low	quality	bright-field	microscopy	that	was	difficult	to	discern.	We	therefore	hypothesize	that	deletion	of	the	BH3	domain	would	be	deleterious	to	APOL1	function,	and	sought	to	determine	the	roles	autophagy	and	the	BH3	domain	have	in	APOL1	cytotoxicity.			 The	APOL	cluster	represents	a	family	of	potential	innate	immunity	genes	(Smith	and	Malik,	2009).	Their	close	relation	due	to	recent	duplications	suggests	the	possibility	of	similar	properties	and	functions.	Indeed,	all	are	induced	by	pro-inflammatory	cytokines	such	as	IFNs.	Additionally,	APOL2	and	6	are	also	predicted	to	contain	BH3	domains,	and	overexpression	of	APOL6	is	pro-apoptotic	and	cytotoxic	in	DLD1	cells,	whereas	APOL2	may	be	anti-apoptotic	in	human	bronchial	epithelial	cells	(Liao	et	al.,	2011;	Liu	et	al.,	2005).	We	hypothesize	that	other	members	of	the	APOL	family	may	be	cytotoxic	when	overexpressed,	and	aim	to	compare	possible	mechanisms	leading	to	cell	death,	including	channel-forming	capabilities.		
Results	
	
The	Putative	BH3	Domain	of	APOL1	is	Dispensable	for	Cytoxicity	and	
Trypanolysis		 We	first	aimed	to	determine	if	deletion	of	the	BH3	domain	rendered	APOL1	non-functional.	The	in	silico	prediction	of	the	APOL1	BH3	domain	is	a	nine-amino	acid	region	just	upstream	of	the	first	predicted	transmembrane	domain.	The	residues	maintained	in	all	BH3	domains	are	L158	and	D163,	with	R159	also	strongly	conserved	(Figure	2A)	(Kelekar	and	Thompson,	1998).	We	converted	all	three	residues	to	alanines	individually	and	in	a	triple	mutant	(APOL1.triplemut).	To	test	
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APOL1	function,	we	challenged	HGD	mice	expressing	APOL1	or	the	indicated	BH3	mutants	with	T.	brucei.		 All	mice	expressing	APOL1.∆BH3	were	killed	by	infection	with	T.	brucei	within	11	days	2	days	earlier	than	those	injected	with	empty	vector	(not	significant).	Mice	expressing	APOL1.WT	and	any	of	the	BH3	single	or	triple	point	mutations	were	completely	protected	for	30	days	(Figure	2B	and	C).	This	demonstrates	that	the	BH3	domain	is	dispensable	for	trypanolysis,	and	that	deletion	of	the	entire	region	renders	APOL1	non-functional.	HDLs	were	purified	from	mouse	serum	two	days	after	HGD	injection	to	ensure	that	manipulation	of	the	BH3	domain	did	not	affect	association	of	APOL1	with	HDL.	Indeed,	mutation	or	deletion	of	the	BH3	domain	had	no	effect	on	HDL	association,	as	APOL1	was	detected	via	immunoblot	in	the	1.0-1.25g/ml	density	fraction	of	serum	that	contained	APOAI		(Figure	2D).			 We	next	tested	to	see	if	the	BH3	domain	was	required	for	cytotoxicity	in	human	HEK293	cells.	Transient	overexpression	of	APOL1.WT	was	cytotoxic,	leading	to	approximately	50%	cell	death	after	48h,	while	APOL1.∆BH3	led	to	no	measurable	cell	death	(Figure	2E).	Importantly,	overexpression	of	APOL1.triplemut	was	also	cytotoxic,	albeit	~30%	less	than	APOL1.WT	(Figure	2F).	This	indicates	that	the	BH3	domain	is	largely	dispensable	for	toxicity	in	mammalian	cell	lines,	but	the	helix	of	which	it	is	part	is	essential.	This	is	consistent	with	the	study	published	along	with	our	collaborators,	where	APOL1	single	and	triple	BH3	mutations	(using	V165	instead	of	R158)	had	no	effect	on	cytotoxicity	in	cRNA	injected	oocytes.	Even	overexpression	of	APOL1	with	the	entire	nine-amino	region	converted	to	alanines	was	cytotoxic,	albeit	significantly	reduced.	Finally,	treatment	of	oocytes	with	the	
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chemical	inhibitor	of	autophagy	wortmannin	had	no	effect	on	cytotoxicity	(Heneghan	et	al.,	2015).	These	data	demonstrate	that	the	putative	BH3	domain	is	not	required	for	APOL1	cytotoxicity	and	that	ACD	does	not	occur.	
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Assessing	the	Cytotoxicity	of	the	APOL	Family		 The	APOL	gene	cluster	encodes	a	family	of	potentially	cytotoxic	proteins.	As	little	is	known	about	the	structure	or	function	of	APOL2-6,	we	began	with	a	comparison	of	linear	structure.	Kyle-Doolittle	hydropathy	plots	were	used	to	compare	the	number	and	location	of	predicted	transmembrane	domains	(Figure	3A).	The	plots	revealed	that	APOLs	1-4,	the	primate-specific	cluster	that	arose	most	recently	due	to	duplication,	contain	2-3	predicted	transmembrane	domains	in	the	same	locations,	including	at	the	C-terminus.	This	suggests	that,	like	APOL1,	APOL2-4	can	potentially	form	ion	channels.	APOL5	and	6	also	contain	1-2	transmembrane	domains,	but	in	different	regions.	We	next	compared	the	cytotoxicity	of	APOL1-6.		 APOL1,	3,	4,	and	6	are	cytotoxic	when	overexpressed	in	HEK293	cells,	whereas	APOL2	and	5	are	not	(Figures	3B	and	3C).	APOL3	was	the	most	cytotoxic	leading	to	nearly	80%	cell	death	and	led	to	a	swollen	cell	phenotype	similar	to	APOL1.	This	was	followed	by	APOL6,	which	caused	approximately	60%	cell	death	and	led	to	a	condensed	cell	phenotype	consistent	with	apoptosis	(Figure	3F).	APOL1	and	4	were	similarly	toxic,	but	no	cell	morphology	changes	were	observed	with	APOL4.	Analysis	of	the	amino	acid	sequences	of	APOL1-6	for	localization	signals	revealed	that	APOL4	contains	a	putative	signal	peptide.	For	APOL1,	the	signal	peptide,	and	therefore	trafficking	through	the	secretory	pathway,	was	required	for	cytotoxicity,	as	the	intracellular	isoform	did	not	cause	any	cell	death	(Figure	3D).	For	APOL4,	expression	of	the	isoform	lacking	a	signal	peptide	led	to	a	modest	reduction	in	toxicity	(Figure	3E).	It	is	unclear	if	the	predicted	signal	peptide	of	
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APOL4	is	functional,	and	we	were	unable	to	test	for	secretion	or	localization	due	to	lack	of	an	antibody.		 There	is	a	lack	of	commercially	available	antibodies	for	APOL2-6.	Therefore,	in	order	to	perform	immunoprecipitation	and	localization	studies,	as	well	as	directly	compare	expression	levels,	we	tagged	APOL1-6.	Myc	or	3xFLAG	tags	were	added	to	the	N-terminus	of	the	APOLs	along	with	a	flexible	2xGGSGG	linker.	For	the	APOL1	isoform	containing	a	signal	peptide,	the	tags	were	inserted	downstream	of	the	signal	peptide	cleavage	site.	Cytotoxicity	of	APOL1	was	largely	unaffected	by	the	N-terminal	myc	tag	(Figure	3A).	Unfortunately,	the	cytotoxicity	of	APOL3,	4,	and	6	was	reduced	by	up	to	5-fold	due	to	tagging	(Figures	3B,	3C,	and	3D).	Tagging	of	the	C-terminus	was	avoided	due	to	its	importance	in	APOL1	channel	assembly	and	possible	oligomerization,	and	a	C-terminal	fusion	of	GFP	to	APOL1	completely	abrogated	cytotoxicity	(Figure	3E).	A	C-terminal	myc	tag	will	be	more	tolerable	than	a	GFP	and	will	be	utilized	for	future	experiments.			 Due	to	similarities	in	cytotoxicity	and	predicted	structure	to	APOL1,	we	hypothesized	that	APOL2-6	could	also	form	ion	channels.	Planar	lipid	bilayer	experiments	and	purifications	were	performed	as	with	rAPOL1.	Only	rAPOL3	and	4	could	be	purified	with	this	method,	and	both	formed	ion	channels	(Data	not	shown.	Experiments	performed	by	Russell	Thomson).	rAPOL3	could	both	insert	into	the	membrane	and	conduct	ions	at	neutral	pH.	Like	rAPOL1,	rAPOL3	is	cation-selective.	rAPOL4	also	functioned	at	neutral	pH,	with	the	added	requirement	of	a	positive	voltage	to	drive	insertion.	These	data	confirm	our	hypothesis	that	the	human	APOL	gene	family	encodes	cytotoxic,	channel	forming	proteins.		
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Discussion	
	
The	Putative	BH3	Domain	of	APOL1	is	Dispensable	for	Cytotoxicity		 Using	a	combination	of	in	vivo	and	in	vitro	techniques,	we	report	that	the	putative	BH3	domain	is	dispensable	for	cytotoxicity	and	that	deletion	of	the	nine-amino	acid	region	renders	the	protein	non-functional.	This	was	confirmed	by	an	in	
vivo	mouse	challenge,	where	APOL1.∆BH3	provided	no	immunity	against	the	animal	infective	T.	brucei.	In	HGD	mice,	APOL1.∆BH3	was	associated	with	circulating	HDL	particles,	indicating	that	the	deletion	likely	affected	channel	formation.	APOL1.∆BH3	was	also	not	toxic	when	overexpressed	in	HEK293	cells,	unlike	APOL1.triplemut,	which	contained	point	mutations	that	would	render	a	classical	BH3	domain	non-functional.	Our	collaborators	corroborated	these	results	by	overexpressing	APOL1	with	the	entire	BH3	domain	substituted	for	alanines.	This	9-alanine	mutant	remained	cytotoxic,	albeit	reduced	compared	to	WT.	These	results	suggest	that	the	cytotoxicity	of	APOL1	is	not	due	to	the	putative	BH3	domain.			 Activation	of	autophagy	has	been	observed	in	many	different	cell	types	expressing	APOL1.	However,	attempts	at	inhibiting	autophagy,	outside	of	the	original	study	by	Wan	et	al,	failed	to	have	rescue	cytotoxicity	(Heneghan	et	al.,	2015;	O'Toole	et	al.,	2018;	Olabisi	et	al.,	2016).	Additionally,	autophagy	may	simply	due	to	expression	of	APOL1	and	not	because	of	its	cytotoxic	effects.	Overexpression	of	APOL1-G1	and	G2	led	to	K+	efflux	in	stably	transfected	TREX293	that	preceded	cell	death,	and	this	cytotoxicity	could	be	rescued	by	culturing	cells	in	media	containing	high	K+	in	place	of	Na+.	Even	with	the	prevention	of	cell	death,	autophagy	was	still	detected	(Olabisi	et	al.,	2016).	Therefore,	while	the	activation	of	autophagy	by	
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APOL1	may	play	an	important	role	in	the	cell,	it	is	not	the	pathway	that	causes	cell	death.		 The	amphipathic	helix	of	the	BH3	domain	is	used	to	direct	binding	to	other	BH-domain	containing	proteins	(Kelekar	and	Thompson,	1998).	Co-expression	of	Beclin-2,	which	negatively	regulates	autophagy	by	binding	the	BH3	domain	of	Beclin-	1	(Maiuri	et	al.,	2007b),	had	no	effect	on	APOL1	cytotoxicity.	Interestingly,	co-expression	with	other	BH-domain	containing	proteins,	such	as	the	anti-apoptotic	myeloid	leukemia	(Mcl)-1,	rescued	APOL1	cytotoxicity.	However,	attempts	to	immunoprecipitate	overexpressed	Mcl-1	and	APOL1	were	not	successful,	indicating	that	this	rescue	was	not	due	to	direct	binding	via	BH	domains	(Heneghan	et	al.,	2015).	The	mechanism	underling	Mcl-1	mediated	from	APOL1	rescue	remains	unknown,	however	it	is	unlikely	to	occur	via	BH3	domain	interaction.		 Further	evidence	demonstrating	that	APOL1	does	not	contain	a	functional	BH3	domain	comes	from	the	cytotoxicity	of	APOL1.triplemut.	Protein:protein	interactions	mediated	by	BH3	domains	can	be	abrogated	by	alanine	point	mutations	in	conserved	residues,	and	APOL1.triplemut	contains	alanines	in	the	three	most	conserved	BH3	residues.	However,	while	this	is	not	a	functional	BH3	domain,	it	may	still	be	integral	for	cytotoxicity	and	trypanolysis.	Overexpression	of	APOL1	with	the	entire	region	substituted	for	alanines	significantly	reduced	cytotoxicity.	Additionally,	substituting	two	glutamic	acids	or	lysines	for	hydrophobic	residues	in	the	region	completely	prevented	trypanolysis	with	rAPOL1	(Vanwalleghem	et	al.,	2015).	However	it	should	be	noted	that	APOL1	is	highly	sensitive	to	small	changes	in	other	domains	as	well,	which	can	be	seen	in	the	case	of	G1	and	G2,	where	a	two	
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amino	acid	substitution	or	deletion	at	the	C-terminus	leads	to	immunity	against	human-infective	trypanosomes.			 To	continue	this	study,	the	channel	properties	of	the	BH3	mutants	and	deletion	should	be	tested	in	planar	lipid	bilayer	experiments.	This	would	reveal	whether	the	BH3	deletion	affects	channel	assembly,	seen	as	the	initial	current	after	acidic	insertion,	or	channel	opening.	In	order	to	further	test	our	hypothesis	that	the	BH3	is	expendable	for	APOL1-mediated	cytotoxicity,	APOL1	and	APOL2	chimeras,	the	latter	of	which	lacks	a	putative	BH3	domain,	can	be	generated	and	tested	for	cytotoxicity.		Additionally,	the	ability	of	Mcl-1	to	rescue	APOL1	cytotoxicity	should	be	pursued	further	in	mammalian	cell	lines	with	functional	programmed	cell	death	pathways.	Finally,	immunoblots	need	to	be	performed	for	transfected	HEK293	cells	to	compare	protein	expression.			 Following	our	study	and	that	of	our	collaborators,	we	conclude	that	APOL1	does	not	contain	a	functional	BH3	domain,	and	that	APOL1	does	not	induce	ACD.		The	APOL	Gene	Family		 Utilizing	an	overexpression	system	we	describe	the	APOL	gene	cluster	as	encoding	a	family	of	cytotoxic,	channel	forming	proteins.	APOL1,	3,	4,	and	6	led	to	cell	death,	with	APOL3	and	6	being	the	most	toxic.	APOL3	led	to	a	swollen	cell	phenotype	also	observed	with	APOL1,	consistent	with	necrosis	and	osmotic	swelling.	Meanwhile,	APOL6	led	to	a	condensed	cell	phenotype	that	is	congruent	with	apoptotic	cell	death.	APOL1-4	have	predicted	transmembrane	domains	in	the	same	regions,	suggesting	the	ability	to	form	ion	channels	like	APOL1.	Indeed,	we	
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discovered	that	rAPOL3	and	4	formed	ion	channels	in	planar	lipid	bilayers.	Finally,	we	report	that	N-terminal	tagging	of	the	APOLs	is	deleterious	for	function.			 These	results	allow	us	to	hypothesize	the	intracellular	function	and	localization	of	the	APOLs.	APOL3	can	form	cation-selective	channels	similar	to	APOL1	without	the	requirement	for	pre-acidification,	indicating	that	cytotoxicity	likely	occurs	from	the	cytoplasm.		APOL4	requires	a	positive	voltage	for	membrane	insertion,	and	as	the	cytoplasm	generally	contains	a	negative	voltage	across	the	plasma	and	organellar	membranes,	this	suggests	that	toxicity	of	APOL4	occurs	elsewhere	in	the	cell,	possibly	within	organelles.	Finally,	APOL6	has	been	reported	to	induce	apoptotic	cell	death	(Liu	et	al.,	2005),	suggesting	it	may	localize	near	the	mitochondria,	where	other	pro	and	anti-apoptotic	proteins	are	typically	found.			 To	further	this	study,	APOL1-6	will	be	tagged	at	the	C-terminus	to	directly	compare	protein	expression	levels	and	to	perform	and	co-immunoprecipitation	studies.	Utilizing	the	tagged	proteins,	we	can	assay	for	co-localization	with	various	intracellular	markers	to	determine	localization.	Combinatorial	expression	of	differentially	tagged	APOLs	will	allow	us	to	assay	for	direct	interactions	and	modulation	of	cytotoxicity.	It	has	already	been	reported	that	overexpressed	APOL1	and	3	interact	(Skorecki	et	al.,	2017).	Additionally,	APOL2	has	been	reported	to	be	anti-apoptotic	(Liao	et	al.,	2011),	suggesting	plausible	interaction	with	APOL6.	We	will	also	attempt	to	purify	APOL2,	5	and	6	and	test	for	their	potential	to	form	ion	channels.	Finally,	to	determine	the	mechanisms	underlying	their	toxicity,	we	will	assay	for	the	activation	of	various	cell	death	pathways.	Importantly,	these	
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experiments	must	be	done	in	cells	competent	for	these	mechanisms,	such	as	bone	marrow	derived	macrophages	from	mice.			 The	APOL	gene	family	remains	largely	untouched	by	research.	A	combination	of	strong	positive	selection	in	the	primate	lineage	along	with	their	induction	by	pro-inflammatory	cytokines	strongly	suggests	that	they	play	an	important	role	in	innate	immunity.	Elucidation	of	their	functions	immunity	has	already	begun,	as	APOL6	was	discovered	to	restrict	poliovirus	infection	(Schoggins	et	al.,	2014),	and	co-expression	of	APOL1	with	HIV	cDNA	in	HEK293	cells	limited	viral	infectivity	(Taylor	et	al.,	2014).	The	other	APOLs	may	also	contribute	to	host	defense,	and	due	to	their	cytotoxic	and	channel	forming	properties,	may	do	so	by	regulating	a	variety	of	cell	death	pathways.	This	study	contains	the	potential	to	significantly	increase	our	understating	of	the	APOLs	and	stimulate	interest	for	further	research.			 											 	
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Chapter	2	
APOL1-G1	and	G2	Form	Ca2+-Permeable	Channels	at	the	
Plasma	Membrane	that	Lead	to	Cell	Death	
	
Introduction		 The	mechanism	underlying	the	cytotoxicity	of	G1	and	G2,	and	thereby	kidney	disease,	remains	unknown.	Multiple	cell	death	mechanisms	have	been	invoked,	and	there	is	little	consensus	on	which	ones	drive	disease.	However,	while	these	mechanisms	seem	disparate,	most	can	be	linked	as	a	cellular	response	to	PFTs.	PFTs	will	activate	multiple	intracellular	signaling	and	inflammatory	pathways	depending	on	their	mechanism	of	action	(Cancino-Rodezno	et	al.,	2010;	Porta	et	al.,	2011).	As	APOL1	forms	cytotoxic	channels	in	trypanosomes,	we	assessed	whether	it	would	kill	mammalian	cells	via	a	similar	mechanism.		 There	is	evidence	that	APOL1	forms	cation-selective	channels	in	animal	cells,	mirroring	its	activity	in	trypanosomes.	Patch-clamping	of	TREX293	or	Xenopus	oocytes	revealed	that	overexpression	of	APOL1	leads	to	a	current	across	the	PM	that	can	be	inhibited	by	an	acidic	pH	below	6.0.	APOL1	also	led	to	the	dissipation	of	cellular	Na+	and	K+	gradients	in	TREX293	cells	(O'Toole	et	al.,	2018).	Interestingly,	overexpression	of	APOL1	in	oocytes	led	to	an	intracellular	accumulation	of	45Ca2+	(Heneghan	et	al.,	2015).	While	APOL1	channel	activity	and	cytotoxicity	regarding	Na+	and	K+	have	been	well	studied,	we	were	interested	in	determining	what	role	the	potent	intracellular	messenger	Ca2+	plays.	Additionally,	we	wanted	to	further	elucidate	the	events	and	kinetics	that	lead	to	APOL1-mediated	cell	death,	as	well	as	the	intracellular	requirements	necessary	for	channel	formation.		
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Results		
Expression	of	APOL1	in	FlpIn	TREX293	Stable	Cell	Lines	Represents	a	Relevant	
Cell	Culture	Model	of	APOL1-Mediated	Kidney	Disease		 			 FlpIn	TREX	293	(FT293)	cell	lines	stably	expressing	a	single	copy	of	doxycycline-inducible	APOL1	G0,	G1,	or	G2	variant	cDNA,	or	empty	vector	cDNA	were	generated.	The	alleles	of	each	APOL1	variant	used	are	the	most	prevalent	in	the	human	population	as	indicated	in	Figure	5A.	Each	cell	line	contained	similar	amounts	of	APOL1	protein	after	4h	induction	with	0.05-50ng/mL	doxycycline	(Figure	5B).	Increasing	the	induction	time	led	to	a	significant	increase	in	cytotoxicity,	as	measured	by	LDH	release,	in	FT293-G1	and	G2,	but	no	G0,	cells	after	20h	of	expression,	with	20-25%	cytotoxicity	observed	after	36h	(Figure	5C).	Additionally,	we	find	that	expression	of	G2	kills	cells	more	rapidly	than	G1,	as	seen	after	20-28h	of	induction.			 It	has	recently	been	proposed	that	overexpression	in	human	cell	lines	is	not	physiologically	relevant	(O'Toole	et	al.,	2018).	However,	O’Toole	et	al	did	not	establish	a	physiological	amount	of	APOL1	expression	for	comparison.	In	order	to	perform	this	comparison,	conditionally	immortalized	podocytes	(Saleem	et	al.,	2002)	were	stimulated	with	0.1-100ng/mL	IFNγ	for	24h	to	induce	APOL1	expression	(Figure	6A).	10ng/mL	IFNγ	induced	maximum	APOL1	expression	in	podocytes	and	was	compared	to	FT293-G0	cells	induced	with	0.08-0.2ng/mL	of	doxycycline	for	24h	(Figures	6B).	
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0.2ng/mL	of	doxycycline	led	to	a	comparable	amount	of	APOL1	protein	expression.	Inducing	FT293-G1	and	G2	cells	with	0.2ng/mL	doxycycline	led	to	cell	swelling	within	24h	(data	not	shown),	5	and	10%	cytotoxicity	by	48h,	and	10	and	15%	cytotoxicity	by	72h,	respectively.	(Figure	6C).	These	findings	indicate	that	the	G1	and	G2	induced	cytotoxicity	in	FT293	cells	occurs	with	a	physiological	amount	of	expression,	and	represents	a	relevant	cell	culture	model	of	APOL1-mediated	chronic	kidney	disease.			
The	APOL1	Channel	Conducts	Ca2+		 A	previous	study	indicated	that	overexpression	of	APOL1	in	Xenopus	oocytes	led	to	an	influx	of	Ca2+	and	cytotoxicity	(Heneghan	et	al.,	2015).	To	investigate	possible	links	between	APOL1	expression,	Ca2+	flux,	and	cytoxicity	we	evaluated	if	the	APOL1	channel	itself	could	conduct	Ca2+;	Only	Na+	and	K+	permeability	have	been	demonstrated	(del	Pilar	Molina-Portela	et	al.,	2005;	Thomson	and	Finkelstein,	2015).	In	the	latter	study	APOL1	was	shown	to	insert	into	planar	lipid	bilayers	at	acidic	pH,	but	opening	of	K+	permeant	channels	required	subsequent	pH	neutralization.	Here	we	replaced	KCl	with	equimolar	CaCl2	on	both	sides	of	the	bilayer	and	show	that	all	three	APOL1	variants	exhibit	a	similar	pH-sensitive	conductance,	enhanced	approximately	450-fold	upon	pH	neutralization	(Figure	7A).	To	examine	ion	selectivity	of	this	conductance,	we	determined	the	reversal	potential	(Erev,	the	voltage	required	to	zero	the	current),	before	and	after	addition	of	CaCl2	to	the	cis	side	to	establish	a	1.95-fold	cis:trans	CaCl2	gradient.	Erev	became	more	negative	after	CaCl2	addition	(changing	from	-1	mV	to	-6	mV),	indicating	selectivity	for	Ca2+	over	Cl-.	By	measuring	Erev	at	multiple	cis:trans	CaCl2	gradients	we	
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established	that	recombinant	APOL1	variants	G0,	G1,	and	G2	were	similarly	permeable	to	Ca2+	(Figure	7B).	These	data	show	that	APOL1	channels	are	permeable	to	Ca2+	and	could	directly	result	in	cellular	Ca2+	flux.			
The	Cytotoxicity	of	APOL1	Requires	Ca2+		 We	tested	the	role	that	Ca2+	may	play	in	APOL1	cytotoxicity	by	altering	the	concentration	of	Ca2+	outside	of	the	cell.	Extracellular	CaCl2	was	adjusted	from	0-4mM	(neglecting	the	~0.2-0.4mM	contributed	by	10%	serum),	and	then	FT293	cells	were	induced	with	50ng/mL	doxycycline	for	24h.	There	was	a	positive	linear	relationship	between	extracellular	Ca2+	and	cytotoxicity,	with	APOL1-G1	and	G2	cytotoxicity	diminished	approximately	4-fold	with	0-1mM	CaCl2,	followed	by	0.5-fold	increase	at	4mM	CaCl2	(Figure	7C).	Even	with	increased	extracellular	Ca2+,	however,	FT293-G0	remains	non-toxic.			 To	ensure	that	the	cytotoxic	effect	was	specific	to	Ca2+,	cells	were	cultured	in	media	containing	2mM	CaCl2	that	was	chelated	with	1.0-1.5mM	EGTA.		After	24h	of	APOL1	expression,	cytotoxicity	in	FT293-G2	cells	was	reduced	approximately	50%	with	the	addition	of	EGTA.	To	test	whether	this	result	could	be	reproduced	with	another	biologically	relevant	divalent	cation,	cells	were	cultured	in	the	presence	of	0.9-3.6mM	MgCl2.	However,	increased	Mg2+	had	little	effect	on	cytotoxicity	(Figure	8),	illustrating	that	this	phenomenon	is	Ca2+-specific.	These	results	suggest	a	pivotal	role	for	Ca2+	in	promoting	APOL1	cytotoxicity,	though	the	requirement	for	Ca2+	influx	and	its	kinetics	must	be	determined.		
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Expression	of	G1	and	G2,	but	not	G0,	Leads	to	an	Increase	in	Intracellular	Ca2+	
that	Precedes	Cell	Swelling	and	Membrane	Damage.				 APOL1	has	been	shown	to	cause	a	flux	of	ions	across	the	PM	when	overexpressed	in	HEK293	cells	or	incubated	with	trypanosomes	(del	Pilar	Molina-Portela	et	al.,	2005;	O'Toole	et	al.,	2018;	Rifkin,	1984),	indicating	that	it	forms	active	ion	channels	within	the	cell.	It	also	leads	to	a	cell	swelling	phenotype	in	both	instances	that	precedes	cell	death.	In	trypanosomes,	this	is	due	to	a	colloidal	osmotic	effect	caused	by	an	increase	of	intracellular	ions,	which	leads	to	the	influx	of	H20	through	aquaporins.	We	hypothesize	that	expression	of	APOL1	leads	to	ion	channel	formation,	which	causes	an	influx	of	Ca2+	that	precedes	cell	swelling	and	death.			 To	study	Ca2+	flux	and	its	kinetics,	FT293	cells	were	transfected	with	the	fluorescent	calcium	indicator	GCaMP6f,	which	provides	a	real-time	fluorescent	readout	of	cytosolic	Ca2+	levels	(Chen	et	al.,	2013).	When	expressed	in	cells,	GCaMP6f	exhibits	low	fluorescence	that	is	increased	upon	an	influx	of	Ca2+,	as	
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demonstrated	by	treatment	with	a	Ca2+	ionophore	(Figure	9,	Movie	1).	To	mark	cells	that	have	experienced	large-scale	membrane	damage	or	undergone	lysis,	the	cell-impermeable	DNA	dye	DRAQ7	was	used.			 FT293-G1	and	G2	cells,	but	not	G0,	exhibit	a	large	increase	in	cytosolic	Ca2+	beginning	approximately	12-18h	after	induction	of	APOL1	expression	with	50ng/mL	doxycycline	(Figure	10,	Movie	2).	Ca2+	influx	in	cells	expressing	G1	and	G2	increases	gradually	over	several	hours	and	occurs	prior	to	cell	swelling,	large	changes	in	cell	morphology,	or	membrane	blebbing	(Figures	11A,	11B	and	11C).		The	cells	typically	remain	swollen	for	12-18h	before	lysis.	The	kinetics	towards	lysis	are	measurably	slower	than	when	cytotoxicity	alone	was	measured	(Figure	5C),	possibly	due	transfection	with	the	GCaMP6f	plasmid.	DRAQ7	was	only	detected	after	cell	lysis,	indicating	that	there	is	no	large,	non-specific	damage	to	the	plasma	membrane	that	allows	for	Ca2+	influx.	On	average,	FT293-G2	cells	displayed	earlier	Ca2+	influx	and	swelling	compared	to	G1,	in	agreement	with	the	findings	of	faster	killing	kinetics	in	Figure	5C.	
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	 High-throughput	microscopy	and	analysis	was	performed	to	rigorously	compare	the	Ca2+-dependent	fluorescence	change	in	each	cell	line	with	and	without	doxycycline	induction,	as	outlined	in	Experimental	Procedures.	A	GCaMP6f	based	fluorescence	threshold	was	established	based	on	the	∆F/F0	observed	in	uninduced	FT293-G0	cells.	Expression	of	G1	and	G2	led	to	an	approximately	4-fold	increase	in	the	percentage	of	cells	above	the	Ca2+-dependent	fluorescence	threshold	compared	to	both	G0	and	uninduced	cells	(Figures	11D	and	11E).	Expression	of	G0	did	not	lead	to	a	measurable	increase	in	cytosolic	Ca2+.	These	data	confirm	that	expression	of	G1	and	G2	leads	to	an	influx	of	extracellular	Ca2+	into	the	cytosol	that	precedes	cell	swelling	and	death,	however	it	does	not	confirm	that	this	is	occurring	directly	through	APOL1	ion	channels	at	the	PM.		
The	Cytotoxicity	of	APOL1	Requires	Trafficking	from	the	Endoplasmic	
Reticulum			 To	ascertain	whether	or	not	APOL1	itself	is	driving	the	Ca2+	influx	as	an	active	ion	channel	at	the	PM,	we	utilized	the	Retention	Using	Selective	Hooks	(RUSH)	system	to	control	and	synchronize	APOL1	trafficking	(Boncompain	et	al.,	2012).	The	RUSH	system	utilizes	a	streptavidin	localized	to	the	ER,	which	binds	to	the	target	protein	that	is	tagged	with	a	streptavidin	binding	peptide	(SBP)	(Figure	12A).	Therefore	the	protein	builds	up	in	the	ER	after	transfection,	and	is	then	synchronously	released	by	addition	of	biotin	to	the	culture	media.	As	the	major	isoform	of	APOL1	contains	a	signal	peptide	and	localizes	to	the	ER,	APOL1	cDNA	was	cloned	into	the	RUSH	system	to	determine	whether	toxicity	was	due	to	localization	in	the	ER	or	trafficking	from	it.	
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	 HEK293	cells	transfected	with	RUSH-APOL1	were	completely	protected	against	the	cytotoxicity	when	G1	and	G2	were	retained	in	the	ER,	which	has	a	neutral	pH	(Figure	12B).	However,	upon	treatment	with	biotin	and	subsequent	trafficking	from	the	ER,	a	20%	increase	in	cytotoxicity	was	observed.	The	cytotoxicity	of	RUSH-G1	and	G2	was	also	exacerbated	2-3-fold	by	increasing	the	extracellular	Ca2+	concentration	to	4	and	8mM	(Figure	13A),	similar	to	in	FT293	cells	(Figure	7C).			 RUSH-G1	exhibits	toxicity	with	slower	kinetics	relative	to	G2	from	6-12h	after	biotin	addition,	which	is	comparable	to	the	results	in	the	FT293	cells	(Figure	5C).	When	retained	in	the	ER,	RUSH-G0,	G1,	and	G2	express	at	similar	levels	(Figure	12C	top	panel).	However,	after	biotin-mediated	release	G0	and	G2	protein	levels	are	reduced	by	approximately	50%,	compared	to	20-25%	in	G1,	indicating	a	difference	in	trafficking	kinetics	or	protein	turnover	(Figure	12C	bottom	panel).			 A	parallel	attempt	to	retain	APOL1	in	the	ER	and	prevent	cytotoxicity	was	performed	by	adding	C-terminal	KDEL	(luminal)	or	KKXX	(cytoplasmic)	retention	signals	(Pelham,	1990;	Vincent	et	al.,	1998).	However,	the	toxicity	of	transiently	overexpressed	APOL1-G0	in	HEK293	cells	was	unaffected	by	either	KDEL	or	KKXX	(Figure	14A).	Pull-down	of	biotinylated	cell-surface	proteins	revealed	similar	levels	of	APOL1,	APOL1:KDEL,	and	APOL1:KKEL	at	the	PM	(Figure	14B),	demonstrating	that	APOL1	could	not	be	held	back	in	the	ER	with	these	C-terminal	retention	signals.			
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APOL1-Mediated	Ca2+	Influx	Requires	Trafficking	from	the	ER.	
	 		 When	expressed	in	stably	transfected	cells,	APOL1	G1	and	G2	led	to	an	influx	of	cytosolic	Ca2+	that	preceded	cell	swelling	(Figures	11A,	11B,	11C,	Movie	2).	We	aimed	to	determine	if	this	phenotype	would	be	observed	with	the	RUSH	system,	and	if	the	Ca2+	influx	would	require	trafficking	of	APOL1	from	the	ER.	Expression	of	RUSH-G1	and	G2	in	HEK293	cells	led	to	a	rapid	increase	in	cytosolic	Ca2+,	as	measured	when	co-expressed	with	GCaMP6f,	which	occurs	before	cell	swelling.	This	phenomenon	is	dependent	upon	release	of	APOL1	from	the	ER		(Figure	15,	Movie	3),	and	displays	faster	kinetics	when	compared	to	the	expression	of	APOL1	in	stably	transfected	FT293	cells,	as	Ca2+	influx	and	cell	swelling	occur	within	2-6h	of	biotin	addition.	Importantly,	DRAQ7	staining	occurred	only	after	the	cells	had	ruptured	(Figures	12D,	12E,	12F,	15,	Movie	3).			 High-throughput	analysis	was	performed	as	before,	with	the	analysis	limited	to	8h	after	biotin	addition,	as	all	cell	swelling	events	occurred	within	that	timeframe.	There	is	an	approximately	3-fold	increase	in	the	amount	of	cells	above	the	Ca2+-dependent	fluorescence	threshold	when	G1	and	G2	are	treated	with	biotin,	demonstrating	that	the	Ca2+	influx	is	dependent	upon	APOL1	trafficking	from	the	ER	(Figure	12G	and	12H).	The	Ca2+	influx	due	to	RUSH-G1	and	G2	trafficking	from	the	ER	was	reproduced	in	CHO	cells	(Figures	13B,	13C,	16,	Movie	4).	These	data	demonstrate	that	the	RUSH	system	faithfully	reproduces	the	results	observed	in	the	stably	transfected	FT293	cells,	but	with	faster	kinetics	and	the	ability	to	synchronize	APOL1	trafficking.		
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APOL1	Localizes	to	the	PM	after	Release	from	the	ER			 Endogenous	APOL1	traffics	to	the	PM	in	IFNγ-stimulated	podocytes	(Scales	et	al.,	2017),	and	PM	localization	was	also	described	in	TREX293	cells	overexpressing	APOL1	(O'Toole	et	al.,	2018).	We	aimed	to	determine	whether	RUSH-APOL1	traffics	to	the	PM	after	addition	of	biotin,	and	if	localization	to	the	PM	occurs	within	a	timeframe	before	Ca2+	influx	is	first	detected.	While	there	is	cell-to-cell	variability,	Ca2+	influx	typically	occurs	within	2-4h	of	biotin	treatment	in	CHO	cells	overexpressing	RUSH-G1	or	G2	(Figure	16,	Movie	4).			 Cell	surface	immunostaining	of	APOL1	revealed	a	significant	increase	in	RUSH-G0	localization	at	the	PM	after	2h	of	biotin	treatment,	which	is	within	the	timeframe	of	observed	Ca2+	influx	for	G1	and	G2,	and	displays	punctate	staining	(Figure	17A).	Quantification	of	mean	fluorescence	intensity	revealed	a	6-fold	increase	in	APOL1	signal	at	the	cell	surface	after	biotin-mediated	release	(Figure	17B).	Several	cells	without	biotin	treatment	display	weak	APOL1	staining,	indicating	a	leak	from	the	ER,	however	the	signal	is	significantly	lower	compared	to	biotin	treated	cells.	Cell	surface	immunostaining	was	subsequently	performed	on	RUSH-G1	and	G2	90min	after	biotin	addition,	revealing	similar	punctate	staining	at	the	PM	between	the	APOL1	variants	(Figure	17C).	Intracellular	RUSH-APOL1	co-localizes	with	the	ER	marker	calnexin	in	untreated	cells,	with	no	detectable	APOL1	at	the	PM	(Figure	18A).	1h	post	biotin	treatment,	APOL1	was	detected	at	the	PM	for	all	variants	(Figure	18B,	top	panel,	arrows),	with	the	majority	of	APOL1	remaining	in	the	ER.	2h	after	biotin-mediated	release,	RUSH-APOL1	was	robustly	detected	at	the	PM	in	all	variants	(Figure	18C),	corroborating	the	cell	surface	immunostaining	
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(Figure	17).	At	this	timepoint,	RUSH-G1	and	G2	led	to	cell	swelling	in	nearly	all	transfected	cells,	which	was	characterized	by	a	rounded	and	bulging	PM	along	with	ER	retratction	from	the	PM	.	These	results	demonstrate	that	RUSH-APOL1	traffics	to	the	PM	before	Ca2+	influx	is	first	detected,	suggesting	that	G1	and	G2	form	cytotoxic	cation	channels	at	the	cell	surface.					 	
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Extracellular	Ca2+	is	the	Source	for	G1	and	G2-Mediated	Influx	and	Cytotoxicity		
	
	 The	ER	is	the	largest	reservoir	of	intracellular	Ca2+,	and	release	of	ER	Ca2+	stores	plays	a	pivotal	role	in	many	signaling	and	cell	death	pathways	(Prakriya	and	Lewis,	2015).	In	order	to	determine	if	ER	Ca2+	release	plays	a	role	in	APOL1-mediated	Ca2+	influx	and	cytotoxicity,	GCaMP6f	was	co-transfected	with	the	ER	Ca2+	sensor	ER-LAR-GECO	(Wu	et	al.,	2014).	Treatment	of	cells	with	the	SERCA	inhibitor	thapsigargin	causes	Ca2+	that	was	destined	for	ER	uptake	to	build	up	in	the	cytosol,	and	can	be	measured	by	the	combination	of	sensors	(Figure	19,	Movie	5).	CHO	cells	were	co-transfected	with	these	sensors	as	well	as	RUSH-APOL1.		Cells	exhibiting	the	established	phenotype	of	cytosolic	Ca2+	increase	and	swelling	following	biotin	treatment	were	analyzed	for	changes	in	ER-LAR-GECO	fluorescence.	We	found	that	while	the	cytosolic	Ca2+	increases,	there	is	no	release	of	Ca2+	from	the	ER	(Figures	20	and	21,	Movie	6).	Rather,	the	ER	Ca2+	levels	remain	steady	or	increase	slightly	in	conjunction	with	the	rise	in	cytosolic	Ca2+,	possibly	as	an	attempt	to	reduce	the	Ca2+	buildup.	However,	the	increase	of	ER	Ca2+	is	inconsistent	between	cells.	The	lack	of	ER	Ca2+	release	indicates	that	the	source	of	Ca2+	in	APOL1	cytotoxicity	is	extracellular,	and	is	likely	conducted	through	G1	and	G2	cation	channels	at	the	PM.		
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Regulation	Along	the	Secretory	Pathway	Likely	Prevents	G0	Cytotoxicity	
	 Pre-acidification	is	a	requirement	for	rAPOL1	to	form	a	functional	channel,	as	it	likely	drives	oligomerization.	As	G0,	G1,	and	G2	form	channels	that	are	equally	permeable	to	Ca2+,	we	hypothesized	that	G0	is	not	cytotoxic	due	to	regulation	along	the	secretory	pathway	that	prevents	acid-driven	oligomerization.	To	circumvent	this	potential	regulation	and	drive	G0	channel	formation,	we	allowed	RUSH-G0	and	G2	to	traffic	to	the	PM	with	4h	of	biotin	treatment.	After	PM	localization,	we	acidified	cells	for	1h	at	pH	5.5,	followed	by	neutralization	and	24h	incubation.	Acidification	of	PM-localized	RUSH-G0	led	to	a	2.5-fold	increase	in	cytotoxicity	compared	to	RUSH-G0	retained	in	the	ER	(Figure	22).	Surprisingly,	acidification	of	cells	with	RUSH-G2	retained	in	the	ER	led	to	an	approximately	4-fold	increase	in	cell	death	compared	to	no	acid.	This	is	likely	due	to	the	leakiness	of	the	RUSH	combined	with	acid	increasing	the	channel	forming	potential	of	APOL1.	Additionally,	acidification	of	cells	will	also	lower	the	pH	of	the	cytosol	and	organelles,	potentially	activating	APOL1	throughout	the	cell.			 These	results	suggest	that	regulation	along	the	secretory	pathway	prevents	G0	oligomerization	and	therefore	cytotoxicity,	perhaps	in	the	form	of	an	SRA-like	chaperone	that	binds	G0	with	higher	affinity	than	G1	or	G2.	G1	and	G2	can	evade	this	interaction	and	form	Ca2+-permeable	channels	at	the	PM,	leading	to	cell	death	and	disease	(Figure	23	A	and	B).								
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Discussion		 A	comprehensive	analysis	using	a	number	genetic,	biochemical,	and	microscopy-based	approaches	revealed	that	the	cytotoxicity	of	G1	and	G2	requires	trafficking	from	the	ER	to	the	PM,	where	it	causes	a	cytotoxic	influx	of	Ca2+.	Using	electrophysiology	to	study	rAPOL1	channel	selectivity,	we	were	able	to	demonstrate	that	the	channel	is	permeable	to	Ca2+,	suggesting	that	APOL1	directly	leads	to	the	observed	Ca2+	influx.	While	G0,	G1,	and	G2	were	equally	permeable	to	Ca2+,	G0	was	not	toxic	in	our	expression	systems.	However,	it	too	led	to	cell	death	if	acidified	and	neutralized	after	PM	localization.	This	supports	our	hypothesis	that	acidification	along	the	secretory	pathway	is	essential	for	cytotoxicity,	and	suggests	a	regulatory	mechanism	or	chaperone	along	this	route	that	prevents	channel	formation	of	G0,	but	not	of	G1	and	G2.	Finally,	as	Ca2+	is	a	potent	signaling	molecule	that	can	activate	many	signaling	and	cell	death	pathways	(Lee	et	al.,	2012b;	Zhivotovsky	and	Orrenius,	2011),	we	propose	that	the	APOL1-mediated	Ca2+	influx	is	the	upstream	event	linking	the	many	APOL1-associated	cell	death	pathways	together.		 We	first	replicated	previously	reported	results	that	G1	and	G2,	but	not	G0,	lead	to	cytotoxicity	when	expressed	in	FT293	cells	(Figure	5C)	(Olabisi	et	al.,	2016).	The	cytotoxicity	was	marked	by	membrane	blebbing	and	a	swollen	cell	phenotype	(Figures	10,	15,	16,	Movies	2,	3,	and	4),	the	latter	of	which	is	also	observed	in	TLF	or	human	serum	treated	trypanosomes.	Importantly,	we	used	the	naturally	occurring	alleles	of	G0,	G1,	and	G2	(Figure	5A).	A	study	by	O’Toole	et	al	reported	that	all	three	variants	were	equally	cytotoxic,	however	in	their	approach	they	added	the	C-terminal	mutations	to	the	G4	allele	(Figure	5A).	The	lytic	activity	of	APOL1	is	highly	
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sensitive	to	even	single	amino	acid	changes	(Cuypers	et	al.,	2016),	highlighting	the	importance	of	using	the	naturally	occurring	alleles	to	draw	relevant	conclusions	on	APOL1	cytotoxicity	and	disease.		 We	are	the	first	to	report	that	the	APOL1	channel	is	permeable	to	Ca2+.	Testing	for	ion	selectivity,	we	discovered	that	the	ERev	of	APOL1-G0,	the	voltage	required	to	zero	the	current,	was	-6mV	with	a	2-fold	cis:trans	gradient	of	CaCl2	(Figure	7A).	An	ideal	Ca2+	channel	would	have	an	ERev	of	-9mV	in	these	conditions.	This	was	true	for	all	three	APOL1	variants	tested	(Figure	7B).	While	this	demonstrates	the	strong	permeability	of	the	APOL1	channel	for	Ca2+,	it	is	in	slight	contrast	to	its	preferences	for	Na+	and	K+,	in	which	it	behaves	as	an	ideal	cation-selective	channel	(Thomson	and	Finkelstein,	2015).	However,	as	the	Ca2+	gradient	between	the	extracellular	environment	and	cytosol	is	approximately	20,000-fold	(Clapham,	2007),	a	channel	with	even	partial	Ca2+	permeability	can	have	large	effects	on	the	cell.		 	The	cation-selectivity	of	APOL1	remains	controversial,	however,	as	others	have	suggested	that	it	is	Cl-	selective.	Cl-	selectivity	was	first	reported	with	a	truncated	rAPOL1	(Perez-Morga	et	al.,	2005),	which	was	later	proven	to	be	non-functional,	as	it	did	not	provide	immunity	against	T.	brucei	in	an	HGD	mouse	experiment	(Molina-Portela	et	al.,	2008).	Cl-	selectivity	was	also	reported	using	KCl	loaded	large	unilamellar	vesicles	(LUVs),	in	which	ionophore-mediated	release	of	K+	from	the	LUVs	was	followed	by	Cl-	efflux	(Bruno	et	al.,	2017).	This	Cl-	selectivity	only	occurred	at	pH	5.0	however,	and	they	found	that	at	pH	7.1	APOL1	was	K+	selective.	While	APOL1	may	indeed	be	permeable	to	Cl-,	it	occurs	at	pH	5.0,	where	only	a	
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negligible	current	is	recorded	in	planar	lipid	bilayers.	Once	neutralized	however,	the	current	increases	450-fold	(Figure	7A),	and	is	driven	by	flux	of	cations.	Therefore,	the	proposed	conductance	of	Cl-	by	APOL1	likely	represents	a	leak.	In	contrast,	the	evidence	for	APOL1	cation-selectivity	is	much	stronger,	due	to	its	dissipation	of	Na+	and	K+	gradients	when	overexpressed	in	animal	cells	or	when	added	to	trypanosomes	(Heneghan	et	al.,	2015;	Olabisi	et	al.,	2016;	Rifkin,	1984),	the	inhibition	of	its	toxicity	in	trypanosomes	when	sodium	is	replaced	by	larger	and	APOL1-impermeant	cations	(del	Pilar	Molina-Portela	et	al.,	2005),	and	the	selectivity	studies	performed	using	planar	lipid	bilayers	(Thomson	and	Finkelstein,	2015).			 We	also	report	that	APOL1	cytotoxicity	is	dependent	upon	extracellular	Ca2+.	The	cytotoxicity	of	APOL1	had	a	positive	linear	relationship	with	extracellular	Ca2+	levels,	and	was	significantly	diminished	by	addition	of	EGTA	or	culturing	cells	in	CaCl2	free	DMEM	(Figures	7C	and	7D).	No	effect	on	cytotoxicity	was	recorded	by	increasing	the	amount	of	another	physiologically	relevant	divalent	cation,	Mg2+	(Figure	8).			 Utilizing	high-throughput	widefield	microscopy	in	cells	expressing	the	cytosolic	Ca2+	sensor	GCaMP6f,	we	demonstrate	that	G1	and	G2,	but	not	G0,	lead	to	a	Ca2+	influx	that	preceded	cell	swelling,	membrane	blebbing,	and	cell	death	(Figure	10,	Movie	2).	The	Ca2+	influx	recorded	in	FT293-G1	and	G2	cells	occurred	gradually,	beginning	12-18h	after	induction	of	APOL1	expression,	and	continued	to	increase	even	after	swelling,	which	usually	lasted	another	12-18h	before	lysis.	Lysis	in	this	experiment	was	delayed	compared	to	when	cytotoxicity	alone	was	measured	via	
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LDH	release	(Figure	5C).	This	may	be	due	to	concurrent	overexpression	of	GCaMP6f.	Importantly,	the	cell-impermeable	DNA	dye	DRAQ7	was	not	detected	until	after	lysis,	demonstrating	that	there	is	no	large	scale	PM	damage.			 We	next	analyzed	over	200	cells	per	genotype	and	condition	from	this	experiment	using	a	Ca2+-dependent	fluorescence	threshold	derived	from	uninduced	FT293-G0	cells.	The	threshold	was	designed	to	differentiate	between	cells	that	had	a	large	and	sustained	increase	in	Ca2+	over	transient	Ca2+	signaling.	This	high-powered	analysis	revealed	that	induction	of	G1	and	G2,	but	not	G0,	led	to	a	4	to	5-fold	increase	in	cells	above	the	fluorescence	threshold	(Figures	11D	and	11E).	While	we	described	an	APOL1-driven	Ca2+	influx	in	this	study,	another	study	reported	no	changes	in	cytosolic	Ca2+	in	TREX293	cells	(O'Toole	et	al.,	2018).	However,	their	approach	utilized	the	dye	Fura-2	measured	via	fluorescent	plate	reader	at	a	single	timepoint	after	induction	of	APOL1	expression,	an	experiment	we	performed	ourselves	yielding	similar	results.	However,	using	the	brighter	and	genetically	encoded	GCaMP6f	and	the	much	more	sensitive	technique	of	fluorescent	microscopy,	combined	with	continuous	analysis	of	hundreds	of	individual	cells	over	time,	allowed	us	to	observe	the	robust	Ca2+	influx	caused	by	G1	and	G2.		 Expression	of	APOL1	in	the	RUSH	system	allowed	us	to	synchronize	its	trafficking	from	the	ER.	We	discovered	that	the	cytotoxicity	of	RUSH-G1	and	G2	required	biotin-mediated	release	from	the	ER,	and	that	LDH	release	started	to	occur	within	6h	(Figure	12B).	Interestingly,	attempts	to	retain	APOL1	in	the	ER	using	the	KDEL	(luminal)	or	KKXX	(cytoplasmic)	retention	signals	failed	(Figures	14A	and	14B).	As	these	signals	are	at	the	C-terminus	where	we	hypothesize	oligomerization	
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occurs,	perhaps	they	were	inaccessible	to	the	KDEL	receptor	and	COPI	and	II	machinery	responsible	for	ER	and	Golgi	recycling	(Dancourt	and	Barlowe,	2010).	We	next	utilized	RUSH	to	demonstrate	that	the	G1	and	G2-mediated	Ca2+	influx	was	dependent	upon	trafficking	from	the	ER	in	both	HEK293	and	CHO	cells	(Figures	12D,	12E,	12F,	15,	16,	Movies	3	and	4).	The	same	high-throughput	analysis	performed	in	Figure	11D	was	applied	to	both	HEK293	and	CHO	cells,	revealing	a	3-4-fold	increase	in	cells	above	the	respective	Ca2+-dependent	fluorescence	threshold	(Figures	12G,	12H,	13B,	and	13C).	We	also	determined	that	the	source	of	Ca2+	for	the	APOL1-mediated	influx	is	extracellular	and	not	released	from	ER	Ca2+	stores	(Figures	20	and	21,	Movie	6).	This	was	performed	by	co-transfecting	RUSH-APOL1,	GCaMP6f,	and	the	ER	Ca2+	sensor	ER-LAR-GECO	into	CHO	cells.	ER	Ca2+	levels	remained	steady	or	increased	slightly	concurrent	to	the	cytosolic	increase.		 We	next	determined	that	APOL1	traffics	to	the	PM	within	the	timeframe	of	Ca2+	influx	first	being	recorded.	Confocal	microscopy	revealed	that	RUSH-G0,	G1	and	G2	led	to	robust	and	punctate	staining	at	the	cell	surface	90min	after	biotin-mediated	release	from	the	ER	(Figure	17).	Intracellular	staining	revealed	RUSH-APOL1	co-localized	with	the	ER	marker	calnexin.	This	co-localization	was	diminished	after	1	and	2h	of	biotin	treatment,	along	with	a	concomitant	increase	of	APOL1	at	the	PM	(Figure	18).	Nearly	all	cells	expressing	RUSH-G1	and	G2	were	swollen	after	2h	of	biotin	treatment,	corroborating	the	phenotype	observed	in	live-cell	microscopy	experiments	(Figure	16,	Movie	4).		Interestingly,	the	ER	had	receded	from	its	association	with	the	PM	in	the	swollen	cells.	A	similar	phenotype	was	observed	in	human	submandibular	gland	cells	treated	with	a	hypotonic	solution,	
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which	caused	a	loss	of	ER:PM	contact	sites	(Liu	et	al.,	2010).	These	data	support	our	hypothesis	that	APOL1	traffics	to	the	PM,	whereupon	G1	and	G2	form	cation	channels	that	lead	to	cell	swelling	and	death.	Our	hypothesis	corroborated	by	other	studies	showing	localization	of	APOL1	at	the	cell	surface	as	well	as	overexpression	of	APOL1	leading	to	a	current	across	the	PM	(Heneghan	et	al.,	2015;	O'Toole	et	al.,	2018;	Scales	et	al.,	2017).			 Finally,	we	discovered	that	RUSH-G0	could	lead	to	cell	death	after	acidification	and	neutralization	upon	PM	localization.	As	APOL1-G0,	G1,	and	G2	are	all	equally	permeable	to	Ca2+	(Figure	7B)	and	have	nearly	identical	channel	forming	properties	(Thomson	and	Finkelstein,	2015),	the	differences	in	cytotoxicity	are	likely	explained	by	differences	in	intracellular	trafficking	or	interaction	with	a	putative	chaperone.	This	result	suggests	that	regulation	along	the	secretory	pathway,	where	acidification	occurs	before	neutralization	at	the	PM,	is	what	prevents	the	cytotoxicity	of	G0.	It	has	long	been	proposed	that	an	SRA-like	chaperone	may	exist	within	the	cell,	possibly	acting	to	prevent	oligomerization	as	SRA	is	hypothesized	to	do,	or	by	altering	the	trafficking	route	of	APOL1.	A	potential	chaperone	was	discovered	in	VAMP8,	a	SNARE	protein	that	facilities	vesicular	fusion	(Madhavan	et	al.,	2017).	Surface	plasmon	resonance	with	truncated	rAPOL1	(C-terminal	residues	305-398)	revealed	that	G0	binds	to	VAMP8,	and	that	this	interaction	is	diminished	with	G1	and	G2.	However,	no	effects	on	G1	and	G2	cytotoxicity	were	reported.	It	is	important	to	continue	this	work	to	see	what	effect	acidification	has	on	RUSH-G0	at	the	PM.	We	hypothesize	that	G0	arrives	at	the	PM	in	
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mostly	monomeric	form,	which	will	oligomerize	and	form	channels	after	acid	treatment.		 The	cytotoxicity	of	APOL1	has	been	linked	to	various	cell	death	pathways.	Overexpression	of	APOL1	stimulates	autophagy.	However,	inhibition	of	this	pathway	had	no	effect	on	toxicity,	signifying	that	autophagy	is	a	secondary	effect	(Olabisi	et	al.,	2016).	APOL1	also	activates	the	stress-activated	kinase	p38	MAPK,	and	inhibition	of	this	pathway	sensitizes	cells	to	sub-lytic	doses	of	PFTs	(Huffman	et	al.,	2004).	Perplexingly,	inhibition	of	MAPK	rescued	TREX293	cells	from	APOL1-mediated	cytotoxicity	(Olabisi	et	al.,	2016).	Mitochondrial	dysfunction	has	also	been	proposed	as	a	mechanism	of	APOL1-mediated	cell	death	(Ma	et	al.,	2017).	We	believe	this	can	be	explained	by	two	factors.	First,	the	cells	become	swollen	for	several	hours	prior	to	lysis,	in	a	state	of	distress	that	likely	affects	mitochondrial	output	(Figures	10,	15,	16,	Movies	2,	3,	and	4).	Additionally,	mitochondria	can	act	as	a	Ca2+	sink	to	regulate	cytosolic	Ca2+	levels.	However,	they	can	be	overloaded	by	uptake	of	too	much	Ca2+,	leading	to	collapse	of	the	mitochondrial	membrane	potential	and	electrochemical	gradient,	leading	to	cell	death	(Rizzuto	et	al.,	2012).	Mitochondrial	dysfunction	may	therefore	drive	necrosis,	but	only	acting	downstream	of	the	APOL1-mediated	Ca2+	influx.			 APOL1	has	also	been	linked	to	pyroptosis,	a	programmed	necrosis	pathway	that	involves	inflammasome	activation	leading	to	pore-formation	by	Gasdermin-D	at	the	PM	(Beckerman	et	al.,	2017).	However,	while	pyroptosis	is	characterized	by	driving	ion	fluxes	across	the	PM,	such	as	Ca2+	influx,	there	is	also	large-scale	PM	damage	detected	via	propidium	iodide	or	Sytox	Green	nuclear	staining	prior	to	lysis	
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(Chen	et	al.,	2016;	de	Vasconcelos	et	al.,	2018).	In	APOL1-mediated	cell	death	there	is	no	nuclear	staining	by	DRAQ7,	a	smaller	cell-impermeant	dye,	until	after	the	cells	have	completely	lysed	(Figures	10	and	15,	Movies	2	and	3),	indicating	that	there	is	no	pore-formation	by	Gasdermin-D.	Additionally,	HEK293	and	CHO	cells	lack	the	necessary	machinery	to	undergo	pyroptosis	unless	components	such	as	Gasdermin-D	are	genetically	introduced	(Bast	et	al.,	2014;	Chen	et	al.,	2016).	It	may	be	possible	that	APOL1	initiates	this	pathway	in	pyroptosis-capable	cell	types	such	as	podocytes	(Haque	et	al.,	2016).	Additionally,	the	NLRP3	inflammasome	can	be	activated	by	an	increase	in	cytosolic	Ca2+	(Lee	et	al.,	2012b).	With	many	pathways	implicated	in	APOL1-mediated	cell	death,	however,	it	is	hard	to	discern	which,	if	any,	is	relevant	to	disease,	or	if	they	all	occur	as	downstream	effects	in	response	to	APOL1	channel	activity.				 The	genetics	of	APOL1	and	kidney	disease	are	complex,	as	disease	is	caused	by	a	recessive	mode	of	inheritance	of	proposed	gain	of	function	mutations	(Genovese	et	al.,	2010).	This	allows	for	heterozygote	advantage,	where	the	carrier	has	no	disease	risk	but	is	protected	against	trypanosomiasis.	We	hypothesize	that	the	lack	of	disease	in	heterozygotes	is	due	to	two	possibilities.	First,	that	the	cytotoxicity	of	G1	and	G2	is	dose-dependent.	This	is	because	the	majority	of	homozygotes	do	not	suffer	from	disease,	indicating	that	G1	and	G2	are	typically	well	tolerated.	It	is	not	until	a	second	hit	occurs,	such	as	an	HIV	infection	or	prolonged	IFN	treatment	that	disease	manifests.	Both	of	these	events	drive	upregulation	of	APOL1	expression	(Nichols	et	al.,	2015).	Second,	it	is	possible	that	G0	is	a	protective	allele.	If	there	is	an	interaction	with	an	SRA-like	chaperone	(Figure	23A),	G0	may	
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form	dimers	with	G1	and	G2	to	prevent	their	cytotoxicity.	Indeed,	HEK293	cells	overexpressing	transgenic	G1	were	partially	rescued	by	CRISPR	activator	upregulation	of	endogenous	G0,	however	a	mechanism	has	yet	to	be	discovered	(Olabisi,	2017).	It	will	be	important	to	further	elucidate	the	molecular	underpinnings	of	APOL1	heterozygote	advantage	in	future	studies	to	better	understand	how	the	manifestation	of	disease.			 This	study	has	increased	our	understanding	of	APOL1-mediated	cytotoxicity	and	thereby	its	role	in	increasing	kidney	disease	risk.		Demonstrating	that	its	cytotoxicity	is	dependent	upon	channel	formation	at	the	PM	should	motivate	further	research	into	blocking	APOL1	channel	conductance	as	a	potential	therapeutic,	rather	than	focusing	on	individual	cell	death	pathways.	Additionally,	highlighting	the	importance	of	acidification	along	the	secretory	pathway	should	lead	to	more	research	on	what	possible	regulatory	mechanisms	exist	along	this	pathway	that	differentiate	the	cytotoxicity	of	G1	and	G2	from	the	non-toxic	G0.		 The	limitations	of	this	work	are	as	follows.	Co-transfection	efficiency	of	RUSH-APOL1	and	GCaMP6f	posed	an	issue,	as	not	all	cells	analyzed	expressed	both	plasmids.	We	attempted	to	overcome	this	drawback	by	performing	high-throughput	analysis.	For	the	triple-transfection	with	ER-LAR-GECO,	we	did	not	perform	the	high-throughput	analysis,	but	rather	analyzed	cells	that	exhibited	the	established	phenotype	of	Ca2+	influx	followed	by	swelling	and	lysis.	To	overcome	the	co-transfection	issue	in	future	experiments,	a	far-red	fluorescent	protein	should	be	cloned	into	the	RUSH	plasmid,	or	treatment	could	be	performed	with	fluorescently	labeled	biotin	to	distinguish	transfected	cells.	For	our	high-throughput	analysis,	the	
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threshold	setting	was	based	on	manually	measuring	the	∆F/F0	of	randomly	sampled	control	cells.	Setting	this	threshold	is	integral	to	quantifying	the	large	datasets,	and	we	aim	to	improve	it	by	encompassing	the	data	from	all	control	cells	to	develop	a	new	method	of	threshold	setting.		 To	complete	the	current	study,	the	following	experiments	will	be	performed.	We	hypothesize	that	the	delays	in	cytotoxicity	and	initiation	of	Ca2+	influx	by	G1	compared	to	G2	(Figures	5C,	10,	11B,	15,	16,	Movies	2,	3,	and	4)	are	due	to	differences	in	trafficking	kinetics.	In	order	to	address	this	question,	we	will	quantify	APOL1	signal	at	the	PM	as	well	as	co-localization	with	the	ER	marker	calnexin	over	several	time	points	from	0-2h	of	biotin	treatment.	To	ascertain	whether	or	not	the	pH-gated	cation	channel	of	APOL1	directly	conducts	Ca2+	influx	at	the	PM,	we	will	perform	live-cell	microscopy	on	cells	co-expressing	RUSH-APOL1	and	GCaMP6f	and	acidify	the	media	after	the	Ca2+	influx	is	first	detected.	If	modulating	the	pH	halts	the	Ca2+	influx,	then	this	demonstrates	that	the	APOL1	channel	is	directly	responsible.	If	not,	then	it	suggests	that	APOL1	channel	activity	initiates	a	cascade	of	events	that	leads	to	Ca2+	influx	via	a	different	mechanism.	We	will	also	perform	this	experiment	with	RUSH-G0	to	determine	if	it	can	initiate	a	Ca2+	influx	after	PM	localization	and	acid	treatment.	Additionally,	the	treatment	of	cells	with	EGTA	to	study	the	effects	of	extracellular	Ca2+	on	cytotoxicity	will	be	expanded	to	all	three	FT293-APOL1	lines.	Finally,	as	RUSH-G0,	G1	and	G2	all	traffic	to	the	PM	after	release	from	the	ER	(Figure	17),	we	will	perform	whole	cell	patch	clamping.	This	will	allow	us	to	compare	channel	activity	between	the	variants	by	measuring	the	reversal	potential	of	the	
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current	across	the	PM,	and	may	provide	insight	about	the	lack	of	cytotoxicity	with	G0	compared	to	that	of	the	kidney	disease	variants.			 To	complement	this	study,	future	work	will	be	aimed	at	identifying	other	events	leading	up	to	APOL1-mediated	cell	death,	using	Ca2+	influx	as	a	reference	point.	APOL1	causes	Na+	influx	along	with	K+	efflux	in	both	trypanosomes	and	mammalian	cells,	which	may	also	lead	to	membrane	depolarization.	Elucidating	the	order	of	events	will	allow	us	to	better	understand	the	context	of	the	Ca2+	influx	and	determine	what	upstream	event	triggers	cell	death.	Interestingly,	it	was	reported	that	rAPOL1	conductance	of	K+	required	Ca2+	in	the	solution	(Bruno	et	al.,	2017).	We	will	assess	what	effects	Ca2+	concentrations	have	on	the	APOL1	conductance	of	Na+	and	K+.	We	are	also	interested	in	determining	if	an	APOL1	chaperone	or	regulatory	mechanism	exists	along	the	secretory	pathway.	Finally,	we	aim	to	elucidate	why	acidification	is	necessary	for	APOL1	cytotoxicity,	and	hypothesize	that	it	leads	to	oligomerization	that	is	necessary	for	channel	assembly.		 In	summary,	we	report	that	the	cytotoxicity	of	APOL1	kidney	disease	risk	variants	G1	and	G2	requires	trafficking	from	the	ER,	whereupon	it	localizes	to	the	PM.	Acidification	and	neutralization	along	the	secretory	pathway	allows	for	channel	formation	at	the	PM	and	leads	to	a	cytotoxic	Ca2+	influx.			
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Chapter	3	
APOL1	and	the	Wound	Healing	Pathways	
	
Introduction		 Ca2+	activated	wound	healing	pathways	promote	cell	survival	in	the	face	of	PFTs	and	PM	damage.	Membrane	that	contains	PFTs	or	has	been	damaged	can	either	be	endocytosed	and	degraded	or	shed	from	the	cell	surface	(Andrews	et	al.,	2014).	Two	independent	repair	pathways	exist:	lysosomal	exocytosis	followed	by	membrane	remodeling	and	endocytosis	(Reddy	et	al.,	2001;	Tam	et	al.,	2010),	or	ESCRT-III	mediated	shedding	(Jimenez	et	al.,	2014;	Scheffer	et	al.,	2014).	Both	pathways	contain	Ca2+	sensing	proteins	that	mobilize	and	recruit	the	necessary	machinery	to	the	wound	site.	As	overexpression	of	APOL1-G1	and	G2	leads	to	Ca2+	influx	and	membrane	blebbing	(Figures	10,	15,	16,	Movies	2,	3,	and	4),	we	hypothesize	that	the	cellular	wound	healing	pathways	are	activated	to	promote	cell	survival.	Evidence	of	wound	repair	would	provide	further	evidence	that	APOL1	forms	Ca2+-selective	channels	that	lead	to	cell	death.		 The	protection	offered	by	wound	healing	pathways	is	both	temporary	and	limited.	Experiments	highlighting	the	cell	survivability	provided	by	these	pathways	are	typically	performed	within	10min	of	PFT	or	Ca2+	ionophore	treatment	(Reddy	et	al.,	2001;	Tam	et	al.,	2010).	Additionally,	repair	capacity	can	be	overwhelmed	by	a	high	dose	of	toxin,	such	as	in	the	case	of	perforin	(PFN).	PFN	is	the	pore-forming	protein	utilized	by	cytotoxic	T	cells	to	deliver	pro-apoptotic	proteases	(granzymes)	
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to	the	target	cell	(Trapani	and	Smyth,	2002).	PFN	forms	pores	in	the	target	cell	membrane,	causing	a	Ca2+	influx	that	leads	to	a	wound	repair	response	that	endocytoses	and	delivers	the	granzymes.	Recreating	this	phenomenon	in	vitro	requires	careful	titration	of	PFN	concentration,	otherwise	the	treatment	will	cause	necrosis	(Keefe	et	al.,	2005).	These	time	and	concentration-dependent	limitations	require	a	more	sensitive	and	fine-tuned	approach	to	APOL1	overexpression.	Here,	we	demonstrate	that	inhibition	of	the	ESCRT-III	pathway	sensitizes	cells	to	APOL1.		
Results		 We	first	expressed	APOL1	in	FT293	cells	with	a	pulse	chase	of	doxycycline.	Rather	than	continuous	exposure	and	overexpression	of	APOL1	as	in	Figure	5B,	cells	were	exposed	to	1h	of	a	lower	amount	of	doxycycline	followed	by	washing	and	a	23h	chase.	Additionally,	as	APOL1	leads	to	cell	swelling	for	several	hours	prior	to	lysis,	we	used	the	MTS	assay,	which	requires	reduction	by	a	metabolically	active	cell,	to	sensitize	our	readout	of	cell	health	prior	to	LDH	release.	Indeed,	pulse	chase	induction	in	FT293-G2	cells	demonstrates	the	increased	sensitivity	in	detecting	dying	cells	(Figure	24A),	as	a	1h	pulse	with	10ng/mL	doxycycline	led	to	60%	loss	in	viability	but	only	a	10%	release	of	LDH.	Next,	we	compared	toxicity	between	24h	of	continuous	APOL1	induction	versus	a	1	or	2h	pulse.	The	1	and	2h	pulse	led	to	a	50%	reduction	in	LDH	release	compared	to	24h	of	continuous	APOL1	expression,	though	max	LDH	release	was	only	5-6%,	and	a	33	(0.64ng/mL	doxycycline)	or	80%	(3.2ng/mL)	increase	in	viability.		(Figures	24B	and	24C).	These	results	suggest	the	
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possibility	that	with	low	levels	of	G2	expression,	the	wound	healing	pathways	prevent	further	cell	death.	
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					 In	order	to	determine	if	lysosomal	wound	repair	is	activated	by	overexpression	of	G2,	we	tested	for	the	presence	of	β-hexosaminidase,	a	lysosomal	enzyme,	in	the	cell	culture	media.	Treatment	of	CHO	cells	with	20µM	and	40µM	of	Ca2+	ionophore	A23187	led	to	a	1.5	and	2.0%	release	of	β-hexosaminidase,	respectively,	(Figure	25A)	without	detection	of	cytosolic	LDH,	which	correlates	with	cell	death	(data	not	shown),	indicating	lysosomal	wound	repair	activation.	However,	treatment	of	FT293	cells	with	the	ionophore	led	to	a	negligible	release	of	β-hexosaminidase	that	could	not	be	explained	by	a	low	amount	of	enzyme	within	the	cell	(Figures	25B	and	25C).	This	was	also	observed	in	the	non-stably	transfected	HEK293	cell	line	(data	not	shown).	This	demonstrates	that	293	cells	are	not	lysosomal	wound	healing	competent,	and	are	therefore	unsuitable	for	studying	this	pathway.			 We	next	tested	for	the	effect	of	ESCRT-III	wound	repair	on	APOL1	cytotoxicity.	Importantly,	ESCRT-III	scission	and	disassembly	requires	ATP	hydrolysis	by	Vps4	(Alonso	et	al.,	2016).	Overexpression	of	Vps4bDN,	which	binds	to	the	complex	but	cannot	hydrolyze	ATP	(Fujita	et	al.,	2003),	significantly	sensitized	cells	to	UV-laser	wounding	(Jimenez	et	al.,	2014).	Accordingly,	we	transfected	FT293-G2	cells	with	Vps4b,	Vps4bDN,	and	an	empty	vector	1d	prior	to	inducing	G2	expression	with	a	1h	pulse	of	doxycycline.	We	found	that	overexpression	of	Vps4bDN	led	to	a	modest	20-30%	increase	of	cytotoxicity	when	G2	was	induced	with	10ng/mL	of	doxycycline	(Figure	25D).	As	the	effect	was	only	
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observed	with	a	higher	amount	of	APOL1	expression,	we	then	expressed	G2	with	continuous	doxycycline	treatment	for	24h.	In	these	conditions,	there	was	no	effect	on	cytotoxicity	by	Vps4bDN,	likely	due	to	the	repair	pathway	being	overwhelmed	(data	not	shown).	These	data	suggested	a	modest	role	at	best	for	ESCRT-III	wound	repair.	However,	we	next	utilized	the	RUSH	expression	system	for	better	temporal	control	over	APOL1	cytotoxicity.			 The	RUSH	system	allows	us	to	control	trafficking	of	APOL1	to	the	PM,	where	wound	repair	occurs.	We	therefore	co-transfected	RUSH-G0	or	G2	along	with	empty,	Vps4b,	and	Vps4bDN	vectors	in	HEK293	cells	and	analyzed	viability	via	the	MTS	assay.	Surprisingly,	overexpression	of	Vps4bDN	led	to	30-40%	loss	in	viability	with	RUSH-G0	after	8	and	24h	of	biotin	release	(Figure	25E).	No	loss	in	viability	was	recorded	in	cells	co-transfected	with	RUSH-G0	and	Vps4b	WT	or	empty	vector.		Additionally,	RUSH-G2	with	Vps4bDN	led	to	a	striking	drop	in	viability	even	without	biotin	treatment,	as	only	25-30%	of	the	transfected	cells	were	viable.	As	the	RUSH	system	is	leaky	(Figures	17A	and	17C),	this	result	suggests	that	the	low	amount	of	G2	that	gets	to	the	PM	is	manageable	(Figure	25E,	G2-Vps4b	WT	without	biotin)	due	to	ESCRT-III	mediated	shedding	(Figure	26).			
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Discussion			 In	this	study,	we	demonstrate	that	ESCRT-III	mediated	budding	promotes	cell	survival	against	the	cytotoxicity	of	APOL1.	We	utilized	the	MTS	assay	to	measure	cell	viability	as	a	sensitive	approach	to	complement	LDH	release.		With	a	pulse	chase	of	APOL1	expression	in	FT293-G2	cells,	cytotoxicity	was	modestly	increased	due	to	Vps4bDN.	The	effect	was	much	more	pronounced	with	RUSH-G2,	where	large-scale	cell	death	was	observed	even	without	biotin-mediated	release.	We	reason	that	this	is	due	to	the	leakiness	of	the	RUSH	system	(Figures	17A	and	17C).		We	also	observed	loss	of	cell	viability	with	RUSH-G0	and	Vps4bDN,	further	supporting	our	hypothesis	that	ESCRT-III	wound	repair	protects	cells	against	APOL1.	Finally,	involvement	of	lysosomal	wound	repair	remains	inconclusive.			 The	combination	of	pulse	chase	expression	of	APOL1	and	the	MTS	assay	allowed	us	to	fine-tune	our	assays.	Use	of	the	MTS	assay	allowed	detection	of	APOL1	toxicity	before	cell	death.	This	likely	occurs	for	two	reasons:	APOL1	causes	cells	to	swell	for	several	hours	prior	to	lysis,	likely	affecting	metabolic	activity,	and	it	has	been	linked	to	mitochondrial	dysfunction	(Ma	et	al.,	2017).	The	pulse	chase	expression	of	APOL1	led	to	diminished	cytotoxicity.	While	this	is	most	likely	due	a	lower	amount	of	APOL1	expression,	the	short	burst	of	induction	may	also	allow	cells	to	repair	themselves.		 Overexpression	of	Vps4bDN	inhibits	ESCRT-III	mediated	budding	and	sensitizes	cells	to	UV-laser	damage	(Jimenez	et	al.,	2014).	It	also	led	to	a	modest	increase	in	cytotoxicity	in	FT293-G2	cells.	The	effect	was	only	seen	with	pulse	chase	expression	of	APOL1	and	not	with	24h	of	continuous	expression.	This	is	likely	due	to	
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ECSRT-III	only	promoting	survival	for	a	short	period	time	and	against	a	low	dose	of	APOL1.	Continuous	overexpression	of	APOL1	will	therefore	overwhelm	the	modest	rescue.	The	temporal	control	of	APOL1	offered	by	the	RUSH	system,	on	the	other	hand,	allowed	us	to	fine-tune	this	assay	further.		 Co-transfection	of	RUSH-APOL1	with	Vps4bDN	significantly	exacerbated	the	cytotoxic	effect	of	APOL1.	This	was	especially	striking	with	RUSH-G0,	which	is	not	cytotoxic	(Figure	12B)	unless	acidified	and	neutralized	after	reaching	the	PM	(Figure	22).	This	result	suggests	that,	when	overexpressed	in	the	RUSH,	a	small	amount	of	G0	oligomerizes	along	the	secretory	pathway	and	forms	channels	at	the	PM,	but	that	those	channels	are	shed	from	the	membrane.	Channel	formation	by	G0	in	this	context	is	likely	due	to	the	synchronization	of	trafficking	by	the	RUSH,	where	the	large	build-up	of	G0	will	traffic	simultaneously	through	the	secretory	pathway,	possibly	overwhelming	any	cell	regulatory	mechanism.	With	RUSH-G2,	an	increase	in	toxicity	was	observed	without	biotin-mediated	release	of	APOL1	from	the	ER.	Due	to	the	leakiness	of	the	RUSH	system	after	48h	of	transfection	(Figures	17A	and	17C),	there	will	be	G2	at	the	PM	even	without	biotin.	This	experiment	demonstrates	that	the	ESCRT-III	machinery	can	handle	the	relatively	low	amount	of	RUSH-G2	that	escapes	the	ER.	In	addition	to	these	findings,	we	discovered	that	APOL1	overexpression	can	cause	membrane	blebbing	(Figures	10,	11B,	15,	16,	Movies	2,	3,	and	4),	and	another	group	reported	APOL1	being	shed	by	HEK293	cells	into	microvesicles	that	contain	the	ESCRT-III	protein	ALIX	(Taylor	et	al.,	2014).	Together,	these	findings	demonstrate	a	role	for	ESCRT-III	in	promoting	cell	survival	against	APOL1	toxicity.		
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	 As	ESCRT-III	is	involved	in	several	cellular	processes	(Alonso	et	al.,	2016)	it	is	important	to	determine	if	its	promotion	of	cell	survival	against	APOL1	occurs	at	the	PM.	In	order	to	do	this,	previous	studies	utilized	cells	expressing	CHMP4B,	an	ESCRT-III	protein	that	physically	drives	budding,	fused	with	GFP.	CHMP4B-GFP	was	recruited	the	UV-damaged	regions	of	the	membrane	(Jimenez	et	al.,	2014).	Co-expressing	CHMP4B-GFP	with	RUSH-APOL1	will	allow	us	to	determine	if	it	becomes	enriched	at	the	PM	after	biotin	treatment,	and	if	there	is	an	increase	with	untreated	RUSH-G1	or	G2	compared	to	G0.	Additionally,	knockouts	of	the	ESCRT-III	recruiting	ALG2	and	ALIX	will	further	reveal	the	contribution	of	this	pathway	to	promoting	survival.		 Attempts	at	assaying	for	the	presence	of	lysosomal	wound	repair	were	unsuccessful.	We	were	unable	to	use	the	FT293	cells	due	to	lack	of	lysosomal	exocytosis	after	Ca2+	ionophore	treatment.	Additionally,	attempts	at	finding	the	lysosomal	marker	Lamp1	at	the	PM	proved	technically	difficult	in	multiple	cell	lines.	We	will	assay	for	lysosomal	wound	repair	using	the	RUSH	system	in	cell	lines	that	are	competent	for	this	pathway.		Additionally,	SytVII	and	acid	sphingomyelinase	are	essential	components	of	this	pathway.	Knocking	out	these	genes	sensitizes	cells	to	PFTs	(Chakrabarti	et	al.,	2003;	Tam	et	al.,	2010),	and	doing	so	with	co-expression	of	
APOL1	will	reveal	if	this	pathway	protects	against	APOL1	toxicity.	However	for	this	current	study,	association	between	lysosomal	wound	healing	and	APOL1	remains	inconclusive.			 The	requirement	of	Ca2+	for	wound	repair	and	survival	against	APOL1	seems	paradoxical	due	to	the	Ca2+	dependence	of	APOL1	toxicity.	Removal	of	extracellular	
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Ca2+	leads	to	a	significant	increase	in	cell	death	when	cells	are	treated	with	PFTs	or	damaged	by	UV-laser	(Jimenez	et	al.,	2014;	Reddy	et	al.,	2001),	but	it	also	prevents	cytotoxicity	by	APOL1	(Figures	7C	and	7D).	It	should	be	noted	that	in	our	experiments	we	did	not	completely	remove	Ca2+	from	the	media	due	to	the	contribution	of	10%	serum	(Figure	7C),	and	doing	so	for	long	assays	would	be	lethal.	Perhaps	both	scenarios	coexist	in	a	middle	ground,	with	a	minimum	amount	of	Ca2+	required	to	protect	cells	against	APOL1.	As	APOL1	is	also	selective	for	Na+	and	K+,	it	is	likely	cytotoxic	even	without	extracellular	Ca2+.	In	order	to	determine	if	having	no	Ca2+	in	the	media	will	sensitive	cells	to	APOL1,	short-term	experiments	will	be	performed	with	RUSH-APOL1.		 In	summary	we	present	evidence	that	the	ESCRT-III	wound	healing	pathway	protects	cells	from	APOL1	toxicity.	This	further	supports	our	hypothesis	that	APOL1	forms	Ca2+-permeable	channels	at	the	PM	that	lead	to	cell	death.					
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Summary		 		 This	study	encompasses	our	attempts	to	elucidate	the	mechanisms	underlying	APOL1	cytotoxicity	and	disease.	We	offer	a	mechanistic	view	of	the	steps	the	kidney	disease	variants	G1	and	G2	require	to	kill	a	cell;	Namely,	trafficking	along	the	secretory	pathway	leads	to	channel	formation	at	the	PM,	causing	a	cytotoxic	influx	of	Ca2+.	We	propose	that	the	cation	channel	is	the	unifying	event	that	leads	to	all	reported	downstream	inflammatory	and	cell	death	pathways,	and	that	inhibiting	its	activity	should	be	the	priority	in	the	fight	against	APOL1-mediated	kidney	disease.	Our	results	suggest	two	possible	targets	for	therapeutics:	blockage	of	the	APOL1	cation	channel,	or	inhibition	of	channel	assembly.	We	hope	that	this	work	will	improve	the	understanding	of	how	APOL1	leads	to	disease.												 			
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Appendix	
	
Digital	Media	
Movie	1.	Validation	of	GCaMP6f	function	in	FT293	cells	(Figure	9).			
Movie	2.	Expression	of	G1	and	G2	leads	to	Ca2+	influx	prior	to	cell	swelling	in	FT293	cells	(Figure	10).		 	
	
Movie	3.	Expression	of	RUSH-G1	and	G2	leads	to	Ca2+	influx,	swelling,	and	lysis	only	after	release	from	the	ER	(Figure	15).	 		
Movie	4.	Expression	and	ER	release	of	RUSH-G1	and	G2	leads	to	Ca2+	influx	and	lysis	in	CHO	cells	(Figure	16).		
Movie	5.	Validating	the	simultaneous	use	of	GCaMP6f	with	the	ER	Ca2+	sensor	ER-LAR-GECO	(Figure	19).		
Movie	6.	APOL1-mediated	increase	of	cytosolic	Ca2+	is	not	due	to	ER	Ca2+	release	(Figure	21).	 			 	 	
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